Skip to main content

Part of the book series: ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY ((AEMB,volume 595))

Abstract

Turmeric, derived from the plant Curcuma longa, is a gold-colored spice commonly used in the Indian subcontinent, not only for health care but also for the preservation of food and as a yellow dye for textiles. Curcumin, which gives the yellow color to turmeric, was first isolated almost two centuries ago, and its structure as diferuloylmethane was determined in 1910. Since the time of Ayurveda (1900 bc) numerous therapeutic activities have been assigned to turmeric for a wide variety of diseases and conditions, including those of the skin, pulmonary, and gastrointestinal systems, aches, pains, wounds, sprains, and liver disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. 1. I. Chattopadhyay, K. Biswas, U. Bandyopadhyay, and R. K. Banerjee, Turmeric and curcumin: Biological actions and medicinal applications. Curr Sci 87, 44–50 (2004).

    CAS  Google Scholar 

  2. 2. F. Abas, N. H. Lajis, K. Shaari, D. A. Israf, J. Stanslas, U. K. Yusuf, and S. M. Raof, A labdane diterpene glucoside from the rhizomes of Curcuma mangga. J Nat Prod 68, 1090–1093 (2005).

    Article  PubMed  CAS  Google Scholar 

  3. 3. W. J. Syu, C. C. Shen, M. J. Don, J. C. Ou, G. H. Lee, and C. M. Sun, Cytotoxicity of curcuminoids and some novel compounds from Curcuma zedoaria. J Nat Prod 61, 1531–1534 (1998).

    Article  PubMed  CAS  Google Scholar 

  4. 4. J. A. Duke, CRC Handbook of Medicinal Spices, 137–144 (2002). CRC Press.

    Google Scholar 

  5. 5. C. Tohda, N. Nakayama, F. Hatanaka, and K. Komatsu, Comparison of anti-inflammatory activities of six curcuma rhizomes: A possible curcuminoid-independent pathway mediated by Curcuma phaeocaulis extract. Evid Based Complement Alternat Med 3, 255–260 (2006).

    Article  PubMed  Google Scholar 

  6. 6. H. Mohamad, N. H. Lajis, F. Abas, A. M. Ali, M. A. Sukari, H. Kikuzaki, and N. Nakatani, Antioxidative constituents of Etlingera elatior. J Nat Prod 68, 285–288 (2005).

    Article  PubMed  CAS  Google Scholar 

  7. 7. T. Dechatowongse, Isolation of constituents from the rhizome of plai (Zingiber cassumunar Rpxb.). Bull Dept Med Sci 18, 75 (1976).

    Google Scholar 

  8. 8. H. Ahsan, N. Parveen, N. U. Khan, and S. M. Hadi, Pro-oxidant, anti-oxidant and cleavage activities on DNA of curcumin and its derivatives demethoxycurcumin and bisdemethoxycurcumin. Chem Biol Interact 121, 161–175 (1999).

    Article  PubMed  CAS  Google Scholar 

  9. 9. N. Sreejayan and M. N. Rao, Free radical scavenging activity of curcuminoids. Arzneimittelforschung 46, 169–171 (1996).

    PubMed  CAS  Google Scholar 

  10. 10. R. Thapliyal and G. B. Maru, Inhibition of cytochrome P450 isozymes by curcumins in vitro and in vivo. Food Chem Toxicol 39, 541–547 (2001).

    Article  PubMed  CAS  Google Scholar 

  11. 11. M. T. Huang, Y. R. Lou, J. G. Xie, W. Ma, Y. P. Lu, P. Yen, B. T. Zhu, H. Newmark, and C. T. Ho, Effect of dietary curcumin and dibenzoylmethane on formation of 7,12-dimethylbenz[a]anthracene-induced mammary tumors and lymphomas/leukemias in Sencar mice. Carcinogenesis 19, 1697–1700 (1998).

    Article  PubMed  CAS  Google Scholar 

  12. 12. Sreejayan and M. N. Rao, Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol 49, 105–107 (1997).

    PubMed  CAS  Google Scholar 

  13. 13. C. Ireson, S. Orr, D. J. Jones, R. Verschoyle, C. K. Lim, J. L. Luo, L. Howells, S. Plummer, R. Jukes, M. Williams, W. P. Steward, and A. Gescher, Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res 61, 1058–1064 (2001).

    PubMed  CAS  Google Scholar 

  14. 14. Y. Sugiyama, S. Kawakishi, and T. Osawa, Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem Pharmacol 52, 519–525 (1996).

    Article  PubMed  CAS  Google Scholar 

  15. 15. S. M. Khopde, K. I. Priyadarsini, S. N. Guha, J. G. Satav, P. Venkatesan, and M. N. Rao, Inhibition of radiation-induced lipid peroxidation by tetrahydrocurcumin: possible mechanisms by pulse radiolysis. Biosci Biotechnol Biochem 64, 503–509 (2000).

    Article  PubMed  CAS  Google Scholar 

  16. 16. K. Okada, C. Wangpoengtrakul, T. Tanaka, S. Toyokuni, K. Uchida, and T. Osawa, Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J Nutr 131, 2090–2095 (2001).

    PubMed  CAS  Google Scholar 

  17. 17. L. Pari and P. Murugan, Protective role of tetrahydrocurcumin against erythromycin estolate-induced hepatotoxicity. Pharmacol Res 49, 481–486 (2004).

    Article  PubMed  CAS  Google Scholar 

  18. 18. L. Pari and D. R. Amali, Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats. J Pharm Pharm Sci 8, 115–123 (2005).

    PubMed  CAS  Google Scholar 

  19. 19. Y. Nakamura, Y. Ohto, A. Murakami, T. Osawa, and H. Ohigashi, Inhibitory effects of curcumin and tetrahydrocurcuminoids on the tumor promoter-induced reactive oxygen species generation in leukocytes in vitro and in vivo. Jpn J Cancer Res 89, 361–370 (1998).

    PubMed  CAS  Google Scholar 

  20. 20. K. R. Chaudhri, Turmeric, haldi or haridra, in eye diseases., Antiseptic. 1950 Jan; 47(1), 67.

    CAS  Google Scholar 

  21. 21. K. M. Nadkarni. Curcuma Longa in India Materia (1976) Popular Prakashan, 414–418 Mumbai.

    Google Scholar 

  22. 22. C. Niederau and E. Gopfert, [The effect of chelidonium- and turmeric root extract on upper abdominal pain due to functional disorders of the biliary system. Results from a placebo-controlled double-blind study]. Med Klin (Munich) 94, 425–430 (1999).

    CAS  Google Scholar 

  23. 23. C. Li, L. Li, J. Luo, and N. Huang, [Effect of turmeric volatile oil on the respiratory tract]. Zhongguo Zhong Yao Za Zhi 23, 624–625, inside back cover (1998).

    PubMed  CAS  Google Scholar 

  24. 24. Curcuma longa (turmeric). Monograph. Altern Med Rev 6(Suppl), S62–S66 (2001).

    Google Scholar 

  25. 25. A. Tawatsin, S. D. Wratten, R. R. Scott, U. Thavara, and Y. Techadamrongsin, repellency of volatile oils from plants against three mosquito vectors. J Vector Ecol 26, 76–82 (2001).

    PubMed  CAS  Google Scholar 

  26. 26. G. Bouvier, M. Hergenhahn, A. Polack, G. W. Bornkamm, and H. Bartsch, Validation of two test systems for detecting tumor promoters and EBV inducers: comparative responses of several agents in DR-CAT Raji cells and in human granulocytes. Carcinogenesis 14, 1573–1578 (1993).

    Article  PubMed  CAS  Google Scholar 

  27. 27. A. P. Saikia, V. K. Ryakala, P. Sharma, P. Goswami. and U. Bora, Ethnobotany of medicinal plants used by Assamese people for various skin ailments and cosmetics. J Ethnopharmacol 106, 149–157 (2006).

    Article  PubMed  Google Scholar 

  28. 28. T. K. Biswas and B. Mukherjee, Plant medicines of Indian origin for wound healing activity: A review. Int J Low Extrem Wounds 2, 25–39 (2003).

    Article  PubMed  Google Scholar 

  29. 29. G. S. Sidhu, A. K. Singh, D. Thaloor, K. K. Banaudha, G. K. Patnaik, R. C. Srimal, and R. K. Maheshwari, Enhancement of wound healing by curcumin in animals. Wound Repair Regen 6, 167–177 (1998).

    Article  PubMed  CAS  Google Scholar 

  30. 30. G. S. Sidhu, H. Mani, J. P. Gaddipati, A. K. Singh, P. Seth, K. K. Banaudha, G. K. Patnaik, and R. K. Maheshwari, Curcumin enhances wound healing in streptozotocin induced diabetic rats and genetically diabetic mice. Wound Repair Regen 7, 362–374 (1999).

    Article  PubMed  CAS  Google Scholar 

  31. 31. T. T. Phan, P. See, S. T. Lee, and S. Y. Chan, Protective effects of curcumin against oxidative damage on skin cells in vitro: its implication for wound healing. J Trauma 51, 927–931 (2001).

    PubMed  CAS  Google Scholar 

  32. 32. T. R. Fray, A. L. Watson, J. M. Croft, C. D. Baker, J. Bailey, N. Sirel, A. Tobias, and P. J. Markwell, A combination of aloe vera, curcumin, vitamin C, and taurine increases canine fibroblast migration and decreases tritiated water diffusion across canine keratinocytes in vitro. J Nutr 134, 2117S–2119S (2004).

    PubMed  CAS  Google Scholar 

  33. 33. D. Gopinath, M. R. Ahmed, K. Gomathi, K. Chitra, P. K. Sehgal, and R. Jayakumar, Dermal wound healing processes with curcumin incorporated collagen films. Biomaterials 25, 1911–1917 (2004).

    Article  PubMed  CAS  Google Scholar 

  34. 34. G. C. Jagetia and G. K. Rajanikant, Role of curcumin, a naturally occurring phenolic compound of turmeric in accelerating the repair of excision wound, in mice whole-body exposed to various doses of gamma-radiation. J Surg Res 120, 127–138 (2004).

    Article  PubMed  CAS  Google Scholar 

  35. 35. G. C. Jagetia and G. K. Rajanikant, Effect of curcumin on radiation-impaired healing of excisional wounds in mice. J Wound Care 13, 107–109 (2004).

    PubMed  CAS  Google Scholar 

  36. 36. G. C. Jagetia and G. K. Rajanikant, Curcumin treatment enhances the repair and regeneration of wounds in mice exposed to hemibody gamma-irradiation. Plast Reconstr Surg 115, 515–528 (2005).

    Article  PubMed  CAS  Google Scholar 

  37. 37. A. Kumar, Y. Takada, A. M. Boriek, and B. B. Aggarwal, Nuclear factor-kappaB: Its role in health and disease. J Mol Med 82, 434–448 (2004).

    Article  PubMed  CAS  Google Scholar 

  38. 38. B. B. Aggarwal, Y. Takada, S. Shishodia, A. M. Gutierrez, O. V. Oommen, H. Ichikawa, Y. Baba, and A. Kumar, Nuclear transcription factor NF-kappa B: Role in biology and medicine. Indian J Exp Biol 42, 341–353 (2004).

    PubMed  CAS  Google Scholar 

  39. 39. H. P. Ammon, M. I. Anazodo, H. Safayhi, B. N. Dhawan, and R. C. Srimal, Curcumin: A potent inhibitor of leukotriene B4 formation in rat peritoneal polymorphonuclear neutrophils (PMNL). Planta Med 58, 226 (1992).

    Article  PubMed  CAS  Google Scholar 

  40. 40. Y. Fujiyama-Fujiwara, R. Umeda, and O. Igarashi, Effects of sesamin and curcumin on delta 5-desaturation and chain elongation of polyunsaturated fatty acid metabolism in primary cultured rat hepatocytes. J Nutr Sci Vitaminol (Tokyo) 38, 353–363 (1992).

    CAS  Google Scholar 

  41. 41. R. Srivastava, Inhibition of neutrophil response by curcumin. Agents Actions 28, 298–303 (1989).

    Article  PubMed  CAS  Google Scholar 

  42. 42. H. P. Ammon, H. Safayhi, T. Mack, and J. Sabieraj, Mechanism of antiinflammatory actions of curcumine and boswellic acids. J Ethnopharmacol 38, 113–119 (1993).

    Article  PubMed  CAS  Google Scholar 

  43. 43. A. C. Reddy and B. R. Lokesh, Studies on anti-inflammatory activity of spice principles and dietary n-3 polyunsaturated fatty acids on carrageenan-induced inflammation in rats. Ann Nutr Metab 38, 349–358 (1994).

    PubMed  CAS  Google Scholar 

  44. 44. B. Joe and B. R. Lokesh, Effect of curcumin and capsaicin on arachidonic acid metabolism and lysosomal enzyme secretion by rat peritoneal macrophages. Lipids 32, 1173–1180 (1997).

    Article  PubMed  CAS  Google Scholar 

  45. 45. Y. X. Xu, K. R. Pindolia, N. Janakiraman, C. J. Noth, R. A. Chapman, and S. C. Gautam, Curcumin, a compound with anti-inflammatory and anti-oxidant properties, down-regulates chemokine expression in bone marrow stromal cells. Exp Hematol 25, 413–422 (1997).

    PubMed  CAS  Google Scholar 

  46. 46. B. Joe and B. R. Lokesh, Dietary n-3 fatty acids, curcumin and capsaicin lower the release of lysosomal enzymes and eicosanoids in rat peritoneal macrophages. Mol Cell Biochem 203, 153–161 (2000).

    Article  PubMed  CAS  Google Scholar 

  47. 47. E. A., Jones, A. Shahed, and D. A. Shoskes, Modulation of apoptotic and inflammatory genes by bioflavonoids and angiotensin II inhibition in ureteral obstruction. Urology 56, 346–351 (2000).

    Article  PubMed  CAS  Google Scholar 

  48. 48. M. Banerjee, L. M. Tripathi, V. M. Srivastava, A. Puri, and R. Shukla, Modulation of inflammatory mediators by ibuprofen and curcumin treatment during chronic inflammation in rat. Immunopharmacol Immunotoxicol 25, 213–224 (2003).

    Article  PubMed  CAS  Google Scholar 

  49. 49. R. C. Lantz, G. J. Chen, A. M. Solyom, S. D. Jolad, and B. N. Timmermann, The effect of turmeric extracts on inflammatory mediator production. Phytomedicine 12, 445–452 (2005).

    Article  PubMed  CAS  Google Scholar 

  50. 50. S. Singh and B. B. Aggarwal, Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J Biol Chem 270, 24,995–25,000 (1995).

    Article  CAS  Google Scholar 

  51. 51. A. Bierhaus, Y. Zhang, P. Quehenberger, T. Luther, M. Haase, M. Muller, N. Mackman, R. Ziegler, and P. P. Nawroth, The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thromb Haemost 77, 772–782 (1997).

    PubMed  CAS  Google Scholar 

  52. 52. A. Munzenmaier, C. Lange, E. Glocker, A. Covacci, A. Moran, S. Bereswill, P. A. Baeuerle, M. Kist, and H. L. Pahl, A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B. J Immunol 159, 6140–6147 (1997).

    PubMed  CAS  Google Scholar 

  53. 53. U. R. Pendurthi, J. T. Williams, and L. V. Rao, Inhibition of tissue factor gene activation in cultured endothelial cells by curcumin. Suppression of activation of transcription factors Egr-1, AP-1, and NF-kappa B. Arterioscler Thromb Vasc Biol 17, 3406–3413 (1997).

    PubMed  CAS  Google Scholar 

  54. 54. Y. X. Xu, K. R. Pindolia, N. Janakiraman, R. A. Chapman, and S. C. Gautam, Curcumin inhibits IL1 alpha and TNF-alpha induction of AP-1 and NF-kB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol 11, 49–62 (1997).

    PubMed  CAS  Google Scholar 

  55. 55. P. Brennan and L. A. O'Neill, Inhibition of nuclear factor kappaB by direct modification in whole cells: Mechanism of action of nordihydroguaiaritic acid, curcumin and thiol modifiers. Biochem Pharmacol 55, 965–973 (1998).

    Article  PubMed  CAS  Google Scholar 

  56. 56. S. S. Han, S. T. Chung, D. A. Robertson, D. Ranjan, and S. Bondada, Curcumin causes the growth arrest and apoptosis of B cell lymphoma by downregulation of egr-1, c-myc, bcl-XL, NF-kappa B, and p53. Clin Immunol 93, 152–161 (1999).

    Article  PubMed  CAS  Google Scholar 

  57. 57. C. Jobin, C. A. Bradham, M. P. Russo, B. Juma, A. S. Narula, D. A. Brenner, and R. B. Sartor, Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol 163, 3474–3483 (1999).

    PubMed  CAS  Google Scholar 

  58. 58. S. M. Plummer, K. A. Holloway, M. M. Manson, R. J. Munks, A. Kaptein, S. Farrow, and L. Howells, Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18, 6013–6020 (1999).

    Article  PubMed  CAS  Google Scholar 

  59. 59. Y. J. Surh, S. S. Han, Y. S. Keum, H. J. Seo, and S. S. Lee, Inhibitory effects of curcumin and capsaicin on phorbol ester-induced activation of eukaryotic transcription factors, NF-kappaB and AP-1. Biofactors 12, 107–112 (2000).

    PubMed  CAS  Google Scholar 

  60. 60. S. E. Chuang, P. Y. Yeh, Y. S. Lu, G. M. Lai, C. M. Liao, M. Gao, and A. L. Cheng, Basal levels and patterns of anticancer drug-induced activation of nuclear factor-kappaB (NF-kappaB), and its attenuation by tamoxifen, dexamethasone, and curcumin in carcinoma cells. Biochem Pharmacol 63, 1709–1716 (2002).

    Article  PubMed  CAS  Google Scholar 

  61. 61. A. Grandjean-Laquerriere, S. C. Gangloff, R. Le Naour, C. Trentesaux, W. Hornebeck, and M. Guenounou, Relative contribution of NF-kappaB and AP-1 in the modulation by curcumin and pyrrolidine dithiocarbamate of the UVB-induced cytokine expression by keratinocytes. Cytokine 18, 168–177 (2002).

    Article  PubMed  CAS  Google Scholar 

  62. 62. S. S. Han, Y. S. Keum, H. J. Seo, and Y. J. Surh, Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells. J Biochem Mol Biol 35, 337–342 (2002).

    PubMed  CAS  Google Scholar 

  63. 63. T. C. Hour, J. Chen, C. Y. Huang, J. Y. Guan, S. H. Lu, and Y. S. Pu, Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation. Prostate 51, 211–218 (2002).

    Article  PubMed  CAS  Google Scholar 

  64. 64. K. S. Chun, Y. S. Keum, S. S. Han, Y. S. Song, S. H. Kim, and Y. J. Surh, Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis 24, 1515–1524 (2003).

    Article  PubMed  CAS  Google Scholar 

  65. 65. S. Philip and G. C. Kundu, Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J Biol Chem 278, 14,487–14,497 (2003).

    CAS  Google Scholar 

  66. 66. S. Shishodia, P. Potdar, C. G. Gairola, and B. B. Aggarwal, Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappaB activation through inhibition of IkappaBalpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24, 1269–1279 (2003).

    Article  PubMed  CAS  Google Scholar 

  67. 67. A. Foryst-Ludwig, M. Neumann, W. Schneider-Brachert and M. Naumann, Curcumin blocks NF-kappaB and the motogenic response in Helicobacter pylori-infected epithelial cells. Biochem Biophys Res Commun 316, 1065–1072 (2004).

    Article  PubMed  CAS  Google Scholar 

  68. 68. I. A. Leclercq, G. C. Farrell, C. Sempoux, A. dela Pena, and Y. Horsmans, Curcumin inhibits NF-kappaB activation and reduces the severity of experimental steatohepatitis in mice. J Hepatol 41, 926–934 (2004).

    Article  PubMed  CAS  Google Scholar 

  69. 69. B. van't Land, N. M. Blijlevens, J. Marteijn, S. Timal, J. P. Donnelly, T. J. de Witte and L. M'Rabet, Role of curcumin and the inhibition of NF-kappaB in the onset of chemotherapy-induced mucosal barrier injury. Leukemia 18, 276–284 (2004).

    Article  PubMed  CAS  Google Scholar 

  70. 70. B. B. Aggarwal, S. Shishodia, Y. Takada, S. Banerjee, R. A. Newman, C. E. Bueso-Ramos and J. E. Price, Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11, 7490–7498 (2005).

    Article  PubMed  CAS  Google Scholar 

  71. 71. S. K. Biswas, D. McClure, L. A. Jimenez, I. L. Megson, and I. Rahman, Curcumin induces glutathione biosynthesis and inhibits NF-kappaB activation and interleukin-8 release in alveolar epithelial cells: mechanism of free radical scavenging activity. Antioxid Redox Signal 7, 32–41 (2005).

    Article  PubMed  CAS  Google Scholar 

  72. 72. M. Farid, M. B. Reid, Y. P. Li, E. Gerken, and W. J. Durham, Effects of dietary curcumin or N-acetylcysteine on NF-kappaB activity and contractile performance in ambulatory and unloaded murine soleus. Nutr Metab (Lond) 2, 20 (2005).

    Article  CAS  Google Scholar 

  73. 73. G. Y. Kim, K. H. Kim, S. H. Lee, M. S. Yoon, H. J. Lee, D. O. Moon, C. M. Lee, S. C. Ahn, Y. C. Park, and Y. M. Park, Curcumin inhibits immunostimulatory function of dendritic cells: MAPKs and translocation of NF-kappa B as potential targets. J Immunol 174, 8116–8124 (2005).

    PubMed  CAS  Google Scholar 

  74. 74. K. W. Lee, J. H. Kim, H. J. Lee, and Y. J. Surh, Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells. Antioxid Redox Signal 7, 1612–1620 (2005).

    Article  PubMed  CAS  Google Scholar 

  75. 75. J. Lee, Y. H. Im, H. H. Jung, J. H. Kim, J. O. Park, K. Kim, W. S. Kim, J. S. Ahn, C. W. Jung, Y. S. Park, W. K. Kang, and K. Park, Curcumin inhibits interferon-alpha induced NF-kappaB and COX-2 in human A549 non-small cell lung cancer cells. Biochem Biophys Res Commun 334, 313–318 (2005).

    Article  PubMed  CAS  Google Scholar 

  76. 76. M. M. LoTempio, M. S. Veena, H. L. Steele, B. Ramamurthy, T. S. Ramalingam, A. N. Cohen, R. Chakrabarti, E. S. Srivatsan, and M. B. Wang, Curcumin suppresses growth of head and neck squamous cell carcinoma. Clin Cancer Res 11, 6994–7002 (2005).

    Article  PubMed  CAS  Google Scholar 

  77. 77. S. Shishodia, H. M. Amin, R. Lai, and B. B. Aggarwal, Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol 70, 700–713 (2005).

    Article  PubMed  CAS  Google Scholar 

  78. 78. S. Wessler, P. Muenzner, T. F. Meyer, and M. Naumann, The anti-inflammatory compound curcumin inhibits Neisseria gonorrhoeae-induced NF-kappaB signaling, release of pro-inflammatory cytokines/chemokines and attenuates adhesion in late infection. Biol Chem 386, 481–490 (2005).

    Article  PubMed  CAS  Google Scholar 

  79. 79. S. Aggarwal, H. Ichikawa, Y. Takada, S. K. Sandur, S. Shishodia, and B. B. Aggarwal, Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IkappaBalpha kinase and Akt activation. Mol Pharmacol 69, 195–206 (2006).

    PubMed  CAS  Google Scholar 

  80. 80. M. Tomita, H. Kawakami, J. N. Uchihara, T. Okudaira, M. Masuda, N. Takasu, T. Matsuda, T. Ohta, Y. Tanaka, K. Ohshiro, and N. Mori, Curcumin (diferuloylmethane) inhibits constitutive active NF-kappaB, leading to suppression of cell growth of human T-cell leukemia virus type I-infected T-cell lines and primary adult T-cell leukemia cells. Int J Cancer 118, 765–772 (2006).

    Article  PubMed  CAS  Google Scholar 

  81. 81. W. M. Weber, L. A. Hunsaker, C. N. Roybal, E. V. Bobrovnikova-Marjon, S. F. Abcouwer, R. E. Royer, L. M. Deck, and D. L. Vander Jagt, Activation of NFkappaB is inhibited by curcumin and related enones. Bioorg Med Chem 14, 2450–2461 (2006).

    Article  PubMed  CAS  Google Scholar 

  82. 82. W. Q. Li, F. Dehnade, and M. Zafarullah, Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway. J Immunol 166, 3491–3498 (2001).

    PubMed  CAS  Google Scholar 

  83. 83. A. C. Bharti, Y. Takada, and B. B. Aggarwal, Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. J Immunol 172, 5940–5947 (2004).

    PubMed  CAS  Google Scholar 

  84. 84. H. Y. Kim, E. J. Park, E. H. Joe, and I. Jou, Curcumin suppresses Janus kinase-STAT inflammatory signaling through activation of Src homology 2 domain-containing tyrosine phosphatase 2 in brain microglia. J Immunol 171, 6072–6079 (2003).

    PubMed  CAS  Google Scholar 

  85. 85. J. Rajasingh, H. P. Raikwar, G. Muthian, C. Johnson, and J. J. Bright, Curcumin induces growth-arrest and apoptosis in association with the inhibition of constitutively active JAK-STAT pathway in T cell leukemia. Biochem Biophys Res Commun 340, 359–368 (2006).

    Article  PubMed  CAS  Google Scholar 

  86. 86. D. Chendil, R. S. Ranga, D. Meigooni, S. Sathishkumar, and M. M. Ahmed, Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene 23, 1599–1607 (2004).

    Article  PubMed  CAS  Google Scholar 

  87. 87. D. A. Dickinson, K. E. Iles, H. Zhang, V. Blank, and H. J. Forman, Curcumin alters EpRE and AP-1 binding complexes and elevates glutamate-cysteine ligase gene expression. FASEB J 17, 473–475 (2003).

    PubMed  CAS  Google Scholar 

  88. 88. B. K. Prusty and B. C. Das, Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin. Int J Cancer 113, 951–960 (2005).

    Article  PubMed  CAS  Google Scholar 

  89. 89. M. Tomita, H. Kawakami, J. N. Uchihara, T. Okudaira, M. Masuda, N. Takasu, T. Matsuda, T. Ohta, Y. Tanaka, and N. Mori, Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines. Leuk Res 30, 313–321 (2006).

    Article  PubMed  CAS  Google Scholar 

  90. 90. U. R. Pendurthi and L. V. Rao, Suppression of transcription factor Egr-1 by curcumin. Thromb Res 97, 179–189 (2000).

    Article  PubMed  CAS  Google Scholar 

  91. 91. E. Balogun, M. Hoque, P. Gong, E. Killeen, C. J. Green, R. Foresti, J. Alam, and R. Motterlini, Curcumin activates the haem oxygenase-1 gene via regulation of Nrf2 and the antioxidant-responsive element. Biochem J 371, 887–895 (2003).

    Article  PubMed  CAS  Google Scholar 

  92. 92. J. Xu, Y. Fu, and A. Chen, Activation of peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of curcumin on rat hepatic stellate cell growth. Am J Physiol Gastrointest Liver Physiol 285, G20–G30 (2003).

    PubMed  CAS  Google Scholar 

  93. 93. S. Zheng and A. Chen, Activation of PPARγ is required for curcumin to induce apoptosis and to inhibit the expression of extracellular matrix genes in hepatic stellate cells in vitro. Biochem J 384, 149–157 (2004).

    Article  PubMed  CAS  Google Scholar 

  94. 94. A. Chen and J. Xu, Activation of PPARγ by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. Am J Physiol Gastrointest Liver Physiol 288, G447–G456 (2005).

    Article  PubMed  CAS  Google Scholar 

  95. 95. A. S. Jaiswal, B. P. Marlow, N. Gupta, and S. Narayan, Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 21, 8414–8427 (2002).

    Article  PubMed  CAS  Google Scholar 

  96. 96. C. H. Park, E. R. Hahm, S. Park, H. K. Kim, and C. H. Yang, The inhibitory mechanism of curcumin and its derivative against beta-catenin/Tcf signaling. FEBS Lett 579, 2965–2971 (2005).

    Article  PubMed  CAS  Google Scholar 

  97. 97. M. M. Chan, Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 49, 1551–1556 (1995).

    Article  PubMed  CAS  Google Scholar 

  98. 98. M. K. Jang, D. H. Sohn, and J. H. Ryu, A curcuminoid and sesquiterpenes as inhibitors of macrophage TNF-alpha release from Curcuma zedoaria. Planta Med 67, 550–552 (2001).

    Article  PubMed  CAS  Google Scholar 

  99. 99. H. Matsuda, S. Tewtrakul, T. Morikawa, A. Nakamura, and M. Yoshikawa, Anti-allergic principles from Thai zedoary: structural requirements of curcuminoids for inhibition of degranulation and effect on the release of TNF-alpha and IL-4 in RBL-2H3 cells. Bioorg Med Chem 12, 5891–5898 (2004).

    Article  PubMed  CAS  Google Scholar 

  100. 100. A. Gulcubuk, K. Altunatmaz, K. Sonmez, D. Haktanir-Yatkin, H. Uzun, A. Gurel and S. Aydin, Effects of curcumin on tumour necrosis factor-alpha and interleukin-6 in the late phase of experimental acute pancreatitis. J Vet Med A Physiol Pathol Clin Med 53, 49–54 (2006).

    PubMed  CAS  Google Scholar 

  101. 101. J. P. Gaddipati, S. V. Sundar, J. Calemine, P. Seth, G. S. Sidhu, and R. K. Maheshwari, Differential regulation of cytokines and transcription factors in liver by curcumin following hemorrhage/resuscitation. Shock 19, 150–156 (2003).

    Article  PubMed  CAS  Google Scholar 

  102. 102. C. J. Lee, J. H. Lee, J. H. Seok, G. M. Hur, Y. C. Park, I. C. Seol, and Y. H. Kim, Effects of baicalein, berberine, curcumin and hesperidin on mucin release from airway goblet cells. Planta Med 69, 523–526 (2003).

    Article  PubMed  CAS  Google Scholar 

  103. 103. N. Jurrmann, R. Brigelius-Flohe and G. F. Bol, Curcumin blocks interleukin-1 (IL-1) signaling by inhibiting the recruitment of the IL-1 receptor-associated kinase IRAK in murine thymoma EL-4 cells. J Nutr 135, 1859–1864 (2005).

    PubMed  CAS  Google Scholar 

  104. 104. Y. Moon, W. C. Glasgow, and T. E. Eling, Curcumin suppresses interleukin 1beta-mediated microsomal prostaglandin E synthase 1 by altering early growth response gene 1 and other signaling pathways. J Pharmacol Exp Ther 315, 788–795 (2005).

    Article  PubMed  CAS  Google Scholar 

  105. 105. M. Shakibaei, G. Schulze-Tanzil, T. John and A. Mobasheri, Curcumin protects human chondrocytes from IL-l1beta-induced inhibition of collagen type II and beta1-integrin expression and activation of caspase-3: An immunomorphological study. Ann Anat 187, 487–497 (2005).

    PubMed  CAS  Google Scholar 

  106. 106. T. Kobayashi, S. Hashimoto and T. Horie, Curcumin inhibition of Dermatophagoides farinea-induced interleukin-5 (IL-5) and granulocyte macrophage-colony stimulating factor (GM-CSF) production by lymphocytes from bronchial asthmatics. Biochem Pharmacol 54, 819–824 (1997).

    Article  PubMed  CAS  Google Scholar 

  107. 107. Y. Abe, S. Hashimoto, and T. Horie, Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages. Pharmacol Res 39, 41–47 (1999).

    Article  PubMed  CAS  Google Scholar 

  108. 108. H. Hidaka, T. Ishiko, T. Furuhashi, H. Kamohara, S. Suzuki, M. Miyazaki, O. Ikeda, S. Mita, T. Setoguchi, and M. Ogawa, Curcumin inhibits interleukin 8 production and enhances interleukin 8 receptor expression on the cell surface:impact on human pancreatic carcinoma cell growth by autocrine regulation. Cancer 95, 1206–1214 (2002).

    Article  PubMed  CAS  Google Scholar 

  109. 109. B. Y. Kang, S. W. Chung, W. Chung, S. Im, S. Y. Hwang, and T. S. Kim, Inhibition of interleukin-12 production in lipopolysaccharide-activated macrophages by curcumin. Eur J Pharmacol 384, 191–195 (1999).

    Article  PubMed  CAS  Google Scholar 

  110. 110. B. Y. Kang, Y. J. Song, K. M. Kim, Y. K. Choe, S. Y. Hwang and T. S. Kim, Curcumin inhibits Th1 cytokine profile in CD4+ T cells by suppressing interleukin-12 production in macrophages. Br J Pharmacol 128, 380–384 (1999).

    Article  PubMed  CAS  Google Scholar 

  111. 111. C. Natarajan and J. J. Bright, Curcumin inhibits experimental allergic encephalomyelitis by blocking IL-12 signaling through Janus kinase-STAT pathway in T lymphocytes. J Immunol 168, 6506–6513 (2002).

    PubMed  CAS  Google Scholar 

  112. 112. M. Tomita, B. J. Holman, C. P. Santoro, and T. J. Santoro, Astrocyte production of the chemokine macrophage inflammatory protein-2 is inhibited by the spice principle curcumin at the level of gene transcription. J Neuroinflammation 2, 8 (2005).

    Article  PubMed  CAS  Google Scholar 

  113. 113. M. K. Bae, S. H. Kim, J. W. Jeong, Y. M. Lee, H. S. Kim, S. R. Kim, I. Yun, S. K. Bae, and K. W. Kim, Curcumin inhibits hypoxia-induced angiogenesis via down-regulation of HIF-1. Oncol Rep 15, 1557–1562 (2006).

    PubMed  CAS  Google Scholar 

  114. 114. H. Choi, Y. S. Chun, S. W. Kim, M. S. Kim, and J. W. Park, Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: A mechanism of tumor growth inhibition. Mol Pharmacol 70(5), 1664–1671 (2006).

    Article  PubMed  CAS  Google Scholar 

  115. 115. S. Reddy and B. B. Aggarwal, Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett 341, 19–22 (1994).

    Article  PubMed  CAS  Google Scholar 

  116. 116. M. Hasmeda and G. M. Polya, Inhibition of cyclic AMP-dependent protein kinase by curcumin. Phytochemistry 42, 599–605 (1996).

    Article  PubMed  CAS  Google Scholar 

  117. 117. Y. R. Chen and T. H. Tan, Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin. Oncogene 17, 173–178 (1998).

    Article  PubMed  CAS  Google Scholar 

  118. 118. M. S. Squires, E. A. Hudson, L. Howells, S. Sale, C. E. Houghton, J. L. Jones, L. H. Fox, M. Dickens, S. A. Prigent, and M. M. Manson, Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells. Biochem Pharmacol 65, 361–376 (2003).

    Article  PubMed  CAS  Google Scholar 

  119. 119. T. H. Leu, S. L. Su, Y. C. Chuang, and M. C. Maa, Direct inhibitory effect of curcumin on Src and focal adhesion kinase activity. Biochem Pharmacol 66, 2323–2331 (2003).

    Article  PubMed  CAS  Google Scholar 

  120. 120. M. Hu, Q. Du, I. Vancurova, X. Lin, E. J. Miller, H. H. Simms, and P. Wang, Proapoptotic effect of curcumin on human neutrophils: activation of the p38 mitogen-activated protein kinase pathway. Crit Care Med 33, 2571–2578 (2005).

    Article  PubMed  CAS  Google Scholar 

  121. 121. L. R. Chaudhary and K. A. Hruska, Inhibition of cell survival signal protein kinase B/Akt by curcumin in human prostate cancer cells. J Cell Biochem 89, 1–5 (2003).

    Article  PubMed  CAS  Google Scholar 

  122. 122. J. Y. Liu, S. J. Lin, and J. K. Lin, Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis 14, 857–861 (1993).

    Article  PubMed  CAS  Google Scholar 

  123. 123. K. J. Mistry, M. Krishna, and R. K. Bhattacharya, Modulation of aflatoxin B1 activated protein kinase C by phenolic compounds. Cancer Lett 121, 99–104 (1997).

    Article  PubMed  CAS  Google Scholar 

  124. 124. P. Varadkar, P. Dubey, M. Krishna, and N. Verma, Modulation of radiation-induced protein kinase C activity by phenolics. J Radiol Prot 21, 361–370 (2001).

    Article  PubMed  CAS  Google Scholar 

  125. 125. J. K. Lin, Suppression of protein kinase C and nuclear oncogene expression as possible action mechanisms of cancer chemoprevention by Curcumin. Arch Pharm Res 27, 683–692 (2004).

    PubMed  CAS  Google Scholar 

  126. 126. S. A. Rushworth, R. M. Ogborne, C. A. Charalambos, and M. A. O'Connell, Role of protein kinase C delta in curcumin-induced antioxidant response element-mediated gene expression in human monocytes. Biochem Biophys Res Commun 341, 1007–1016 (2006).

    Article  PubMed  CAS  Google Scholar 

  127. 127. R. L. Hong, W. H. Spohn, and M. C. Hung, Curcumin inhibits tyrosine kinase activity of p185neu and also depletes p185neu. Clin Cancer Res 5, 1884–1891 (1999).

    PubMed  CAS  Google Scholar 

  128. 128. T. Dorai, N. Gehani, and A. Katz, Therapeutic potential of curcumin in human prostate cancer. II. Curcumin inhibits tyrosine kinase activity of epidermal growth factor receptor and depletes the protein. Mol Urol 4, 1–6 (2000).

    PubMed  CAS  Google Scholar 

  129. 129. S. Kaul and T. P. Krishnakanth, Effect of retinol deficiency and curcumin or turmeric feeding on brain Na(+)−K+ adenosine triphosphatase activity. Mol Cell Biochem 137, 101–107 (1994).

    Article  PubMed  CAS  Google Scholar 

  130. 130. J. G. Bilmen, S. Z. Khan, M. H. Javed, and F. Michelangeli, Inhibition of the SERCA Ca2+ pumps by curcumin. Curcumin putatively stabilizes the interaction between the nucleotide-binding and phosphorylation domains in the absence of ATP. Eur J Biochem 268, 6318–6327 (2001).

    Article  PubMed  CAS  Google Scholar 

  131. 131. M. J. Logan-Smith, P. J. Lockyer, J. M. East and A. G. Lee, Curcumin, a molecule that inhibits the Ca2+-ATPase of sarcoplasmic reticulum but increases the rate of accumulation of Ca2 +. J Biol Chem 276, 46,905–46.911 (2001).

    CAS  Google Scholar 

  132. 132. Y. A. Mahmmoud, Curcumin modulation of Na, K-ATPase: phosphoenzyme accumulation, decreased K+ occlusion, and inhibition of hydrolytic activity. Br J Pharmacol 145, 236–245 (2005).

    Article  PubMed  CAS  Google Scholar 

  133. 133. J. Kang, J. Chen, Y. Shi, J. Jia, and Y. Zhang, Curcumin-induced histone hypoacetylation: The role of reactive oxygen species. Biochem Pharmacol 69, 1205–1213 (2005).

    Article  PubMed  CAS  Google Scholar 

  134. 134. W. H. Liu, X. M. Chen, and B. Fu, Thrombin stimulates MMP-9 mRNA expression through AP-1 pathway in human mesangial cells. Acta Pharmacol Sin 21, 641–645 (2000).

    PubMed  CAS  Google Scholar 

  135. 135. S. Shimizu, S. Jareonkitmongkol, H. Kawashima, K. Akimoto, and H. Yamada, Inhibitory effect of curcumin on fatty acid desaturation in Mortierella alpina 1S-4 and rat liver microsomes. Lipids 27, 509–512 (1992).

    Article  PubMed  CAS  Google Scholar 

  136. 136. H. Kawashima, K. Akimoto, S. Jareonkitmongkol, N. Shirasaka, and S. Shimizu, Inhibition of rat liver microsomal desaturases by curcumin and related compounds. Biosci Biotechnol Biochem 60, 108–110 (1996).

    PubMed  CAS  Google Scholar 

  137. 137. X. Chen, T. Hasuma, Y. Yano, T. Yoshimata, Y. Morishima, Y. Wang, and S. Otani, Inhibition of farnesyl protein transferase by monoterpene, curcumin derivatives and gallotannin. Anticancer Res 17, 2555–2564 (1997).

    PubMed  CAS  Google Scholar 

  138. 138. H. M. Kang, K. H. Son, D. C. Yang, D. C. Han, J. H. Kim, N. I. Baek, and B. M. Kwon, Inhibitory activity of diarylheptanoids on farnesyl protein transferase. Nat Prod Res 18, 295–299 (2004).

    Article  PubMed  CAS  Google Scholar 

  139. 139. M. Susan and M. N. Rao, Induction of glutathione S-transferase activity by curcumin in mice. Arzneimittelforschung 42, 962–964 (1992).

    PubMed  CAS  Google Scholar 

  140. 140. M. L. Iersel, J. P. Ploemen, I. Struik, C. van Amersfoort, A. E. Keyzer, J. G. Schefferlie, and P. J. van Bladeren, Inhibition of glutathione S-transferase activity in human melanoma cells by alpha, beta-unsaturated carbonyl derivatives. Effects of acrolein, cinnamaldehyde, citral, crotonaldehyde, curcumin, ethacrynic acid, and trans-2-hexenal. Chem Biol Interact 102, 117–132 (1996).

    Article  PubMed  CAS  Google Scholar 

  141. 141. J. T. Piper, S. S. Singhal, M. S. Salameh, R. T. Torman, Y. C. Awasthi, and S. Awasthi, Mechanisms of anticarcinogenic properties of curcumin: The effect of curcumin on glutathione linked detoxification enzymes in rat liver. Int J Biochem Cell Biol 30, 445–456 (1998).

    Article  PubMed  CAS  Google Scholar 

  142. 142. S. S. Singhal, S. Awasthi, U. Pandya, J. T. Piper, M. K. Saini, J. Z. Cheng, and Y. C. Awasthi, The effect of curcumin on glutathione-linked enzymes in K562 human leukemia cells. Toxicol Lett 109, 87–95 (1999).

    Article  PubMed  CAS  Google Scholar 

  143. 143. S. Awasthi, U. Pandya, S. S. Singhal, J. T. Lin, V. Thiviyanathan, W. E. Seifert, Jr., Y. C. Awasthi, and G. A. Ansari, Curcumin-glutathione interactions and the role of human glutathione S-transferase P1-1. Chem Biol Interact 128, 19–38 (2000).

    Article  PubMed  CAS  Google Scholar 

  144. 144. R. A. Sharma, C. R. Ireson, R. D. Verschoyle, K. A. Hill, M. L. Williams, C. Leuratti, M. M. Manson, L. J. Marnett, W. P. Steward, and A. Gescher, Effects of dietary curcumin on glutathione S-transferase and malondialdehyde-DNA adducts in rat liver and colon mucosa: Relationship with drug levels. Clin Cancer Res 7, 1452–1458 (2001).

    PubMed  CAS  Google Scholar 

  145. 145. A. Duvoix, F. Morceau, S. Delhalle, M. Schmitz, M. Schnekenburger, M. M. Galteau, M. Dicato, and M. Diederich, Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition. Biochem Pharmacol 66, 1475–1483 (2003).

    Article  PubMed  CAS  Google Scholar 

  146. 146. R. Blasius, A. Duvoix, F. Morceau, M. Schnekenburger, S. Delhalle, E. Henry, M. Dicato, and M. Diederich, Curcumin stability and its effect on glutathione S-transferase P1-1 mRNA expression in K562 cells. Ann N Y Acad Sci 1030, 442–448 (2004).

    Article  PubMed  CAS  Google Scholar 

  147. 147. N. Hill-Kapturczak, V. Thamilselvan, F. Liu, H. S. Nick and A. Agarwal, Mechanism of heme oxygenase-1 gene induction by curcumin in human renal proximal tubule cells. Am J Physiol Renal Physiol 281, F851–F859 (2001).

    PubMed  CAS  Google Scholar 

  148. 148. G. Scapagnini, R. Foresti, V. Calabrese, A. M. Giuffrida Stella, C. J. Green and R. Motterlini, Caffeic acid phenethyl ester and curcumin: a novel class of heme oxygenase-1 inducers. Mol Pharmacol 61, 554–561 (2002).

    Article  PubMed  CAS  Google Scholar 

  149. 149. E. Balogun, R. Foresti, C. J. Green, and R. Motterlini, Changes in temperature modulate heme oxygenase-1 induction by curcumin in renal epithelial cells. Biochem Biophys Res Commun 308, 950–955 (2003).

    Article  PubMed  CAS  Google Scholar 

  150. 150. V. Calabrese, D. A. Butterfield, and A. M. Stella, Nutritional antioxidants and the heme oxygenase pathway of stress tolerance: Novel targets for neuroprotection in Alzheimer's disease. Ital J Biochem 52, 177–181 (2003).

    PubMed  CAS  Google Scholar 

  151. 151. J. Gaedeke, N. A. Noble, and W. A. Border, Curcumin blocks fibrosis in anti-Thy 1 glomerulonephritis through up-regulation of heme oxygenase 1. Kidney Int 68, 2042–2049 (2005).

    Article  PubMed  CAS  Google Scholar 

  152. 152. H. Yamamoto, K. Hanada, K. Kawasaki, and M. Nishijima, Inhibitory effect on curcumin on mammalian phospholipase D activity. FEBS Lett 417, 196–198 (1997).

    Article  PubMed  CAS  Google Scholar 

  153. 153. Y. P. Lu, R. L. Chang, M. T. Huang, and A. H. Conney, Inhibitory effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced increase in ornithine decarboxylase mRNA in mouse epidermis. Carcinogenesis 14, 293–297 (1993).

    Article  PubMed  CAS  Google Scholar 

  154. 154. C. V. Rao, B. Simi, and B. S. Reddy, Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 14, 2219–2225 (1993).

    Article  PubMed  CAS  Google Scholar 

  155. 155. C. Ishizaki, T. Oguro, T. Yoshida, C. Q. Wen, H. Sueki, and M. Iijima, Enhancing effect of ultraviolet A on ornithine decarboxylase induction and dermatitis evoked by 12-O-tetradecanoylphorbol-13-acetate and its inhibition by curcumin in mouse skin. Dermatology 193, 311–317 (1996).

    Article  PubMed  CAS  Google Scholar 

  156. 156. Y. Okazaki, M. Iqbal and S. Okada, Suppressive effects of dietary curcumin on the increased activity of renal ornithine decarboxylase in mice treated with a renal carcinogen, ferric nitrilotriacetate. Biochim Biophys Acta 1740, 357–366 (2005).

    PubMed  CAS  Google Scholar 

  157. 157. C. Ramachandran, H. B. Fonseca, P. Jhabvala, E. A. Escalon, and S. J. Melnick, Curcumin inhibits telomerase activity through human telomerase reverse transcritpase in MCF-7 breast cancer cell line. Cancer Lett 184, 1–6 (2002).

    Article  PubMed  CAS  Google Scholar 

  158. 158. S. Chakraborty, U. Ghosh, N. P. Bhattacharyya, R. K. Bhattacharya, and M. Roy, Inhibition of telomerase activity and induction of apoptosis by curcumin in K-562 cells. Mutat Res 596, 81–90 (2006).

    PubMed  CAS  Google Scholar 

  159. 159. J. K. Lin and C. A. Shih, Inhibitory effect of curcumin on xanthine dehydrogenase/oxidase induced by phorbol-12-myristate-13-acetate in NIH3T3 cells. Carcinogenesis 15, 1717–2171 (1994).

    Article  PubMed  CAS  Google Scholar 

  160. 160. I. Brouet and H. Ohshima, Curcumin, an anti-tumour promoter and anti–inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun 206, 533–540 (1995).

    Article  PubMed  CAS  Google Scholar 

  161. 161. M. M. Chan, H. I. Huang, M. R. Fenton, and D. Fong, In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 55, 1955–1962 (1998).

    Article  PubMed  CAS  Google Scholar 

  162. 162. K. F. Soliman and E. A. Mazzio, In vitro attenuation of nitric oxide production in C6 astrocyte cell culture by various dietary compounds. Proc Soc Exp Biol Med 218, 390–397 (1998).

    PubMed  CAS  Google Scholar 

  163. 163. M. Onoda and H. Inano, Effect of curcumin on the production of nitric oxide by cultured rat mammary gland. Nitric Oxide 4, 505–515 (2000).

    Article  PubMed  CAS  Google Scholar 

  164. 164. M. H. Pan, S. Y. Lin-Shiau and J. K. Lin, Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages. Biochem Pharmacol 60, 1665–1676 (2000).

    Article  PubMed  CAS  Google Scholar 

  165. 165. H. Narang and M. Krishna, Inhibition of radiation induced nitration by curcumin and nicotinamide in mouse macrophages. Mol Cell Biochem 276, 7–13 (2005).

    Article  PubMed  CAS  Google Scholar 

  166. 166. A. Mukhopadhyay, S. Banerjee, L. J. Stafford, C. Xia, M. Liu, and B. B. Aggarwal, Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21, 8852–8861 (2002).

    Article  PubMed  CAS  Google Scholar 

  167. 167. T. Choudhuri, S. Pal, T. Das, and G. Sa, Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J Biol Chem 280, 20,059–20,068 (2005).

    Article  CAS  Google Scholar 

  168. 168. Y. K. Kwon, J. M. Jun, S. W. Shin, J. W. Cho, and S. I. Suh, Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells. Int J Oncol 26, 1597–1603 (2005).

    PubMed  CAS  Google Scholar 

  169. 169. D. Bech-Otschir, R. Kraft, X. Huang, P. Henklein, B. Kapelari, C. Pollmann, and W. Dubiel, COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. Embo J 20, 1630–1639 (2001).

    Article  PubMed  CAS  Google Scholar 

  170. 170. P. J. Moos, K. Edes, J. E. Mullally, and F. A. Fitzpatrick, Curcumin impairs tumor suppressor p53 function in colon cancer cells. Carcinogenesis 25, 1611–1617 (2004).

    Article  PubMed  CAS  Google Scholar 

  171. 171. P. Tsvetkov, G. Asher, V. Reiss, Y. Shaul, L. Sachs, and J. Lotem, Inhibition of NAD(P)H:quinone oxidoreductase 1 activity and induction of p53 degradation by the natural phenolic compound curcumin. Proc Natl Acad Sci USA 102, 5535–5540 (2005).

    Article  PubMed  CAS  Google Scholar 

  172. 172. S. S. Kakar and D. Roy, Curcumin inhibits TPA induced expression of c-fos, c-jun and c-myc proto-oncogenes messenger RNAs in mouse skin. Cancer Lett 87, 85–59 (1994).

    Article  PubMed  CAS  Google Scholar 

  173. 173. M. T. Huang, W. Ma, Y. P. Lu, R. L. Chang, C. Fisher, P. S. Manchand, H. L. Newmark, and A. H. Conney, Effects of curcumin, demethoxycurcumin, bisdemethoxycurcumin and tetrahydrocurcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Carcinogenesis 16, 2493–2497 (1995).

    Article  PubMed  CAS  Google Scholar 

  174. 174. Y. P. Lu, R. L. Chang, Y. R. Lou, M. T. Huang, H. L. Newmark, K. R. Reuhl, and A. H. Conney, Effect of curcumin on 12-O-tetradecanoylphorbol-13-acetate- and ultraviolet B light-induced expression of c-Jun and c-Fos in JB6 cells and in mouse epidermis. Carcinogenesis 15, 2363–2370 (1994).

    Article  PubMed  CAS  Google Scholar 

  175. 175. P. Limtrakul, S. Anuchapreeda, S. Lipigorngoson and F. W. Dunn, Inhibition of carcinogen induced c-Ha-ras and c-fos proto-oncogenes expression by dietary curcumin. BMC Cancer 1, 1 (2001).

    Article  PubMed  CAS  Google Scholar 

  176. 176. K. Nakamura, Y. Yasunaga, T. Segawa, D. Ko, J. W. Moul, S. Srivastava, and J. S. Rhim, Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines. Int J Oncol 21, 825–830 (2002).

    PubMed  CAS  Google Scholar 

  177. 177. M. T. Huang, T. Lysz, T. Ferraro, T. F. Abidi, J. D. Laskin, and A. H. Conney, Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res 51, 813–819 (1991).

    PubMed  CAS  Google Scholar 

  178. 178. F. Zhang, N. K. Altorki, J. R. Mestre, K. Subbaramaiah, and A. J. Dannenberg, Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis 20, 445–451 (1999).

    Article  PubMed  CAS  Google Scholar 

  179. 179. A. Goel, C. R. Boland, and D. P. Chauhan, Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett 172, 111–118 (2001).

    Article  PubMed  CAS  Google Scholar 

  180. 180. J. W. Cho, K. Park, G. R. Kweon, B. C. Jang, W. K. Baek, M. H. Suh, C. W. Kim, K. S. Lee, and S. I. Suh, Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets. Exp Mol Med 37, 186–192 (2005).

    PubMed  CAS  Google Scholar 

  181. 181. R. G. Tunstall, R. A. Sharma, S. Perkins, S. Sale, R. Singh, P. B. Farmer, W. P. Steward, and A. J. Gescher, Cyclooxygenase-2 expression and oxidative DNA adducts in murine intestinal adenomas: Modification by dietary curcumin and implications for clinical trials. Eur J Cancer 42, 415–421 (2006).

    Article  PubMed  CAS  Google Scholar 

  182. 182. D. L. Flynn, M. F. Rafferty, and A. M. Boctor, Inhibition of 5-hydroxy-eicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally-occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. Prostaglandins Leukot Med 22, 357–360 (1986).

    Article  PubMed  CAS  Google Scholar 

  183. 183. J. Hong, M. Bose, J. Ju, J. H. Ryu, X. Chen, S. Sang, M. J. Lee, and C. S. Yang, Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25, 1671–1679 (2004).

    Article  PubMed  CAS  Google Scholar 

  184. 184. N. S. Prasad, R. Raghavendra, B. R. Lokesh, and K. A. Naidu, Spice phenolics inhibit human PMNL 5-lipoxygenase. Prostaglandins Leukot Essent Fatty Acids 70, 521–528 (2004).

    Article  PubMed  CAS  Google Scholar 

  185. 185. P. F. Firozi, V. S. Aboobaker, and R. K. Bhattacharya, Action of curcumin on the cytochrome P450-system catalyzing the activation of aflatoxin B1. Chem Biol Interact 100, 41–51 (1996).

    Article  PubMed  CAS  Google Scholar 

  186. 186. H. P. Ciolino, P. J. Daschner, T. T. Wang, and G. C. Yeh, Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells. Biochem Pharmacol 56, 197–206 (1998).

    Article  PubMed  CAS  Google Scholar 

  187. 187. R. Thapliyal, S. S. Deshpande, and G. B. Maru, Effects of turmeric on the activities of benzo(a)pyrene-induced cytochrome P-450 isozymes. J Environ Pathol Toxicol Oncol 20, 59–63 (2001).

    PubMed  CAS  Google Scholar 

  188. 188. T. Sugiyama, J. Nagata, A. Yamagishi, K. Endoh, M. Saito, K. Yamada, S. Yamada, and K. Umegaki, Selective protection of curcumin against carbon tetrachloride-induced inactivation of hepatic cytochrome P450 isozymes in rats. Life Sci 78, 2188–2193 (2006).

    Article  PubMed  CAS  Google Scholar 

  189. 189. M. J. Van Erk, E. Teuling, Y. C. Staal, S. Huybers, P. J. Van Bladeren, J. M. Aarts, and B. Van Ommen, Time- and dose-dependent effects of curcumin on gene expression in human colon cancer cells. J Carcinog 3, 8 (2004).

    Article  PubMed  Google Scholar 

  190. 190. C. Yan, M. S. Jamaluddin, B. Aggarwal, J. Myers, and D. D. Boyd, Gene expression profiling identifies activating transcription factor 3 as a novel contributor to the proapoptotic effect of curcumin. Mol Cancer Ther 4, 233–241 (2005).

    PubMed  CAS  Google Scholar 

  191. 191. H. M. Wortelboer, M. Usta, A. E. van der Velde, M. G. Boersma, B. Spenkelink, J. J. van Zanden, I. M. Rietjens, P. J. van Bladeren, and N. H. Cnubben, Interplay between MRP inhibition and metabolism of MRP inhibitors: the case of curcumin. Chem Res Toxicol 16, 1642–1651 (2003).

    Article  PubMed  CAS  Google Scholar 

  192. 192. W. Chearwae, S. Anuchapreeda, K. Nandigama, S. V. Ambudkar, and P. Limtrakul, Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II, and III purified from Turmeric powder. Biochem Pharmacol 68, 2043–2052 (2004).

    Article  PubMed  CAS  Google Scholar 

  193. 193. P. Limtrakul, S. Anuchapreeda, and D. Buddhasukh, Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. BMC Cancer 4, 13 (2004).

    Article  PubMed  Google Scholar 

  194. 194. W. Chearwae, C. P. Wu, H. Y. Chu, T. R. Lee, S. V. Ambudkar, and P. Limtrakul, Curcuminoids purified from turmeric powder modulate the function of human multidrug resistance protein 1 (ABCC1). Cancer Chemother Pharmacol 57, 376–388 (2006).

    Article  PubMed  CAS  Google Scholar 

  195. 195. X. Q. Tang, H. Bi, J. Q. Feng, and J. G. Cao, Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Acta Pharmacol Sin 26, 1009–1016 (2005).

    Article  PubMed  CAS  Google Scholar 

  196. 196. J. Lee, H. H. Jung, Y. H. Im, J. H. Kim, J. O. Park, K. Kim, W. S. Kim, J. S. Ahn, C. W. Jung, Y. S. Park, W. K. Kang, and K. Park, Interferon-alpha resistance can be reversed by inhibition of IFN-alpha-induced COX-2 expression potentially via STAT1 activation in A549 cells. Oncol Rep 15, 1541–1549 (2006).

    PubMed  CAS  Google Scholar 

  197. 197. C. Park, G. Y. Kim, G. D. Kim, B. T. Choi, Y. M. Park, and Y. H. Choi, Induction of G2/M arrest and inhibition of cyclooxygenase-2 activity by curcumin in human bladder cancer T24 cells. Oncol Rep 15, 1225–1231 (2006).

    PubMed  CAS  Google Scholar 

  198. 198. W. J. Durham, S. Arbogast, E. Gerken, Y. P. Li, and M. B. Reid, Progressive nuclear factor-kappaB activation resistant to inhibition by contraction and curcumin in mdx mice. Muscle Nerve 34(3), 298–303 (2006).

    Article  PubMed  CAS  Google Scholar 

  199. 199. C. C. Su, G. W. Chen, J. G. Lin, L. T. Wu, and J. G. Chung, Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B/p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res 26, 1281–1288 (2006).

    PubMed  CAS  Google Scholar 

  200. 200. N. Chakravarti, J. N. Myers, and B. B. Aggarwal, Targeting constitutive and interleukin-6-inducible signal transducers and activators of transcription 3 pathway in head and neck squamous cell carcinoma cells by curcumin (diferuloylmethane). Int J Cancer 119(6), 1268–1275 (2006).

    Article  PubMed  CAS  Google Scholar 

  201. 201. A. M. Siddiqui, X. Cui, R. Wu, W. Dong, M. Zhou, M. Hu, H. H. Simms, and P. Wang, The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-gamma*. Crit Care Med 34(7), 1874–1882 (2006).

    Article  PubMed  CAS  Google Scholar 

  202. 202. H. C. Huang, T. R. Jan, and S. F. Yeh, Inhibitory effect of curcumin, an anti-inflammatory agent, on vascular smooth muscle cell proliferation. Eur J Pharmacol 221, 381–384 (1992).

    Article  PubMed  CAS  Google Scholar 

  203. 203. L. Korutla and R. Kumar, Inhibitory effect of curcumin on epidermal growth factor receptor kinase activity in A431 cells. Biochim Biophys Acta 1224, 597–600 (1994).

    Article  PubMed  Google Scholar 

  204. 204. J. F. Santibanez, M. Quintanilla, and J. Martinez, Genistein and curcumin block TGF-beta 1-induced u-PA expression and migratory and invasive phenotype in mouse epidermal keratinocytes. Nutr Cancer 37, 49–54 (2000).

    Article  PubMed  CAS  Google Scholar 

  205. 205. R. Mohan, J. Sivak, P. Ashton, L. A. Russo, B. Q. Pham, N. Kasahara, M. B. Raizman, and M. E. Fini, Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem 275, 10,405–10,512 (2000).

    Article  CAS  Google Scholar 

  206. 206. S. C. Shih and K. P. Claffey, Role of AP-1 and HIF-1 transcription factors in TGF-beta activation of VEGF expression. Growth Factors 19, 19–34 (2001).

    PubMed  CAS  Google Scholar 

  207. 207. H. Mani, G. S. Sidhu, R. Kumari, J. P. Gaddipati, P. Seth and R. K. Maheshwari, Curcumin differentially regulates TGF-beta1, its receptors and nitric oxide synthase during impaired wound healing. Biofactors 16, 29–43 (2002).

    PubMed  CAS  Google Scholar 

  208. 208. A. E. Gururaj, M. Belakavadi, D. A. Venkatesh, D. Marme, and B. P. Salimath, Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun 297, 934–942 (2002).

    Article  PubMed  CAS  Google Scholar 

  209. 209. J. Gaedeke, N. A. Noble, and W. A. Border, Curcumin blocks multiple sites of the TGF-beta signaling cascade in renal cells. Kidney Int 66, 112–120 (2004).

    Article  PubMed  CAS  Google Scholar 

  210. 210. P. C. Smith, J. F. Santibanez, J. P. Morales, and J. Martinez, Epidermal growth factor stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts. Possible modulation by genistein and curcumin. J Periodontal Res 39, 380–387 (2004).

    Article  PubMed  CAS  Google Scholar 

  211. 211. A. Chen, J. Xu, and A. C. Johnson, Curcumin inhibits human colon cancer cell growth by suppressing gene expression of epidermal growth factor receptor through reducing the activity of the transcription factor Egr-1. Oncogene 25, 278–287 (2006).

    PubMed  Google Scholar 

  212. 212. J. H. Kim, C. Xu, Y. S. Keum, B. Reddy, A. Conney, and A. N. Kong, Inhibition of EGFR signaling in human prostate cancer PC-3 cells by combination treatment with beta-phenylethyl isothiocyanate and curcumin. Carcinogenesis 27, 475–482 (2006).

    Article  PubMed  CAS  Google Scholar 

  213. 213. S. Zheng and A. Chen, Curcumin suppresses the expression of extracellular matrix genes in activated hepatic stellate cells by inhibiting gene expression of connective tissue growth factor. Am J Physiol Gastrointest Liver Physiol 290, G883–G893 (2006).

    Article  PubMed  CAS  Google Scholar 

  214. 214. A. Masamune, N. Suzuki, K. Kikuta, M. Satoh, K. Satoh, and T. Shimosegawa, Curcumin blocks activation of pancreatic stellate cells. J Cell Biochem 97, 1080–1093 (2006).

    Article  PubMed  CAS  Google Scholar 

  215. 215. X. Yang, D. P. Thomas, X. Zhang, B. W. Culver, B. M. Alexander, W. J. Murdoch, M. N. Rao, D. A. Tulis, J. Ren, and N. Sreejayan, Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arterioscler Thromb Vasc Biol 26, 85–90 (2006).

    Article  PubMed  CAS  Google Scholar 

  216. 216. Y. Takada, A. Bhardwaj, P. Potdar, and B. B. Aggarwal, Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene 23, 9247–9258 (2004).

    PubMed  CAS  Google Scholar 

  217. 217. J. M. Dogne, J. Hanson, C. Supuran, and D. Pratico, Coxibs and cardiovascular side-effects: from light to shadow. Curr Pharm Des 12, 971–975 (2006).

    Article  PubMed  CAS  Google Scholar 

  218. 218. A. T. Chan, J. E. Manson, C. M. Albert, C. U. Chae, K. M. Rexrode, G. C. Curhan, E. B. Rimm, W. C. Willett, and C. S. Fuchs, Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation 113, 1578–1587 (2006).

    Article  PubMed  CAS  Google Scholar 

  219. 219. M. Hermann and F. Ruschitzka, Coxibs, non-steroidal anti-inflammatory drugs and cardiovascular risk. Intern Med J 36, 308–319 (2006).

    Article  PubMed  CAS  Google Scholar 

  220. 220. B. Gupta and B. Ghosh, Curcuma longa inhibits TNF-alpha induced expression of adhesion molecules on human umbilical vein endothelial cells. Int J Immunopharmacol 21, 745–757 (1999).

    Article  PubMed  CAS  Google Scholar 

  221. 221. B. Madan and B. Ghosh, Diferuloylmethane inhibits neutrophil infiltration and improves survival of mice in high-dose endotoxin shock. Shock 19, 91–96 (2003).

    Article  PubMed  CAS  Google Scholar 

  222. 222. B. Fuller, S. Dijk, P. Butler, V. Hoang, and B. Davidson, Pro-inflammatory agents accumulate during donor liver cold preservation: A study on increased adhesion molecule expression and abrogation by curcumin in cultured endothelial cells. Cryobiology 46, 284–288 (2003).

    Article  PubMed  CAS  Google Scholar 

  223. 223. O. P. Sharma, Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 25, 1811–1812 (1976).

    Article  PubMed  CAS  Google Scholar 

  224. 224. V. K. Shalini and L. Srinivas, Lipid peroxide induced DNA damage: protection by turmeric (Curcuma longa). Mol Cell Biochem 77, 3–10 (1987).

    Article  PubMed  CAS  Google Scholar 

  225. 225. M. Nagabhushan, U. J. Nair, A. J. Amonkar, A. V. D'Souza, and S. V. Bhide, Curcumins as inhibitors of nitrosation in vitro. Mutat Res 202, 163–169 (1988).

    PubMed  CAS  Google Scholar 

  226. 226. I. A. Donatus, Sardjoko, and N. P. Vermeulen, Cytotoxic and cytoprotective activities of curcumin. Effects on paracetamol-induced cytotoxicity, lipid peroxidation and glutathione depletion in rat hepatocytes. Biochem Pharmacol 39, 1869–1875 (1990).

    Article  PubMed  CAS  Google Scholar 

  227. 227. S. C. Sahu and M. C. Washington, Effect of ascorbic acid and curcumin on quercetin-induced nuclear DNA damage, lipid peroxidation and protein degradation. Cancer Lett 63, 237–241 (1992).

    Article  PubMed  CAS  Google Scholar 

  228. 228. K. K. Soudamini, M. C. Unnikrishnan, K. B. Soni, and R. Kuttan, Inhibition of lipid peroxidation and cholesterol levels in mice by curcumin. Indian J Physiol Pharmacol 36, 239–243 (1992).

    PubMed  CAS  Google Scholar 

  229. 229. M. K. Unnikrishnan and M. N. Rao, Curcumin inhibits nitrite-induced methemoglobin formation. FEBS Lett 301, 195–196 (1992).

    Article  PubMed  CAS  Google Scholar 

  230. 230. B. Joe and B. R. Lokesh, Role of capsaicin, curcumin and dietary n-3 fatty acids in lowering the generation of reactive oxygen species in rat peritoneal macrophages. Biochim Biophys Acta 1224, 255–263 (1994).

    Article  PubMed  CAS  Google Scholar 

  231. 231. D. V. Rajakumar and M. N. Rao, Antioxidant properties of dehydrozingerone and curcumin in rat brain homogenates. Mol Cell Biochem 140, 73–79 (1994).

    Article  PubMed  CAS  Google Scholar 

  232. 232. A. C. Reddy and B. R. Lokesh, Effect of dietary turmeric (Curcuma longa) on iron-induced lipid peroxidation in the rat liver. Food Chem Toxicol 32, 279–283 (1994).

    Article  PubMed  CAS  Google Scholar 

  233. 233. A. C. Reddy and B. R. Lokesh, Studies on the inhibitory effects of curcumin and eugenol on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol Cell Biochem 137, 1–8 (1994).

    Article  PubMed  CAS  Google Scholar 

  234. 234. Sreejayan and M. N. Rao, Curcuminoids as potent inhibitors of lipid peroxidation. J Pharm Pharmacol 46, 1013–1016 (1994).

    PubMed  CAS  Google Scholar 

  235. 235. R. Selvam, L. Subramanian, R. Gayathri, and N. Angayarkanni, The anti-oxidant activity of turmeric (Curcuma longa). J Ethnopharmacol 47, 59–67 (1995).

    Article  PubMed  CAS  Google Scholar 

  236. 236. M. K. Unnikrishnan and M. N. Rao, Inhibition of nitrite induced oxidation of hemoglobin by curcuminoids. Pharmazie 50, 490–492 (1995).

    PubMed  CAS  Google Scholar 

  237. 237. M. K. Unnikrishnan and M. N. Rao, Curcumin inhibits nitrogen dioxide induced oxidation of hemoglobin. Mol Cell Biochem 146, 35–37 (1995).

    Article  PubMed  CAS  Google Scholar 

  238. 238. S. Kaul and T. P. Krishnakantha, Influence of retinol deficiency and curcumin/turmeric feeding on tissue microsomal membrane lipid peroxidation and fatty acids in rats. Mol Cell Biochem 175, 43–48 (1997).

    Article  PubMed  CAS  Google Scholar 

  239. 239. A. Nogaki, K. Satoh, K. Iwasaka, H. Takano, M. Takahama, Y. Ida, and H. Sakagami, Radical intensity and cytotoxic activity of curcumin and gallic acid. Anticancer Res 18, 3487–3491 (1998).

    PubMed  CAS  Google Scholar 

  240. 240. S. Bhaumik, M. D. Jyothi, and A. Khar, Differential modulation of nitric oxide production by curcumin in host macrophages and NK cells. FEBS Lett 483, 78–82 (2000).

    Article  PubMed  CAS  Google Scholar 

  241. 241. S. Kapoor and K. I. Priyadarsini, Protection of radiation-induced protein damage by curcumin. Biophys Chem 92, 119–126 (2001).

    Article  PubMed  CAS  Google Scholar 

  242. 242. M. R. Kelly, J. Xu, K. E. Alexander, and G. Loo, Disparate effects of similar phenolic phytochemicals as inhibitors of oxidative damage to cellular DNA. Mutat Res 485, 309–318 (2001).

    PubMed  CAS  Google Scholar 

  243. 243. T. Masuda, T. Maekawa, K. Hidaka, H. Bando, Y. Takeda, and H. Yamaguchi, Chemical studies on antioxidant mechanism of curcumin: analysis of oxidative coupling products from curcumin and linoleate. J Agric Food Chem 49, 2539–2547 (2001).

    Article  PubMed  CAS  Google Scholar 

  244. 244. K. C. Das and C. K. Das, Curcumin (diferuloylmethane), a singlet oxygen ((1)O(2)) quencher. Biochem Biophys Res Commun 295, 62–66 (2002).

    Article  PubMed  CAS  Google Scholar 

  245. 245. G. K. Jayaprakasha, B. S. Jena, P. S. Negi, and K. K. Sakariah, Evaluation of antioxidant activities and antimutagenicity of turmeric oil: a byproduct from curcumin production. Z Naturforsch [C] 57, 828–835 (2002).

    CAS  Google Scholar 

  246. 246. R. Toniolo, F. Di Narda, S. Susmel, M. Martelli, L. Martelli, and G. Bontempelli, Quenching of superoxide ions by curcumin. A mechanistic study in acetonitrile. Ann Chim 92, 281–288 (2002).

    PubMed  CAS  Google Scholar 

  247. 247. M. Balasubramanyam, A. A. Koteswari, R. S. Kumar, S. F. Monickaraj, J. U. Maheswari, and V. Mohan, Curcumin-induced inhibition of cellular reactive oxygen species generation: novel therapeutic implications. J Biosci 28, 715–721 (2003).

    PubMed  CAS  Google Scholar 

  248. 248. A. Betancor-Fernandez, A. Perez-Galvez, H. Sies, and W. Stahl, Screening pharmaceutical preparations containing extracts of turmeric rhizome, artichoke leaf, devil's claw root and garlic or salmon oil for antioxidant capacity. J Pharm Pharmacol 55, 981–986 (2003).

    Article  PubMed  CAS  Google Scholar 

  249. 249. S. M. Chauhan, A. S. Kandadai, N. Jain, and A. Kumar, Biomimetic oxidation of curcumin with hydrogen peroxide catalyzed by 5,10,15,20-tetraarylporphyrinatoiron(III) chlorides in dichloromethane. Chem Pharm Bull (Tokyo) 51, 1345–1347 (2003).

    Article  CAS  Google Scholar 

  250. 250. M. Iqbal, Y. Okazaki and S. Okada, In vitro curcumin modulates ferric nitrilotriacetate (Fe-NTA) and hydrogen peroxide (H2O2)-induced peroxidation of microsomal membrane lipids and DNA damage. Teratog Carcinog Mutagen 1(Suppl), 151–160 (2003).

    Article  PubMed  CAS  Google Scholar 

  251. 251. B. D. Johnston and E. G. DeMaster, Suppression of nitric oxide oxidation to nitrite by curcumin is due to the sequestration of the reaction intermediate nitrogen dioxide, not nitric oxide. Nitric Oxide 8, 231–234 (2003).

    Article  PubMed  CAS  Google Scholar 

  252. 252. R. Rukkumani, M. Sri Balasubashini, and V. P. Menon, Protective effects of curcumin and photo-irradiated curcumin on circulatory lipids and lipid peroxidation products in alcohol and polyunsaturated fatty acid-induced toxicity. Phytother Res 17, 925–929 (2003).

    Article  PubMed  CAS  Google Scholar 

  253. 253. V. Eybl, D. Kotyzova, and M. Bludovska, The effect of curcumin on cadmium-induced oxidative damage and trace elements level in the liver of rats and mice. Toxicol Lett 151, 79–85 (2004).

    Article  PubMed  CAS  Google Scholar 

  254. 254. S. Fujisawa, T. Atsumi, M. Ishihara, and Y. Kadoma, Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. Anticancer Res 24, 563–569 (2004).

    PubMed  CAS  Google Scholar 

  255. 255. M. O. Iwunze and D. McEwan, Peroxynitrite interaction with curcumin solubilized in ethanolic solution. Cell Mol Biol (Noisy-le-grand) 50, 749–752 (2004).

    CAS  Google Scholar 

  256. 256. C. Kalpana and V. P. Menon, Modulatory effects of curcumin on lipid peroxidation and antioxidant status during nicotine-induced toxicity. Pol J Pharmacol 56, 581–586 (2004).

    PubMed  CAS  Google Scholar 

  257. 257. R. K. Kempaiah and K. Srinivasan, Influence of dietary curcumin, capsaicin and garlic on the antioxidant status of red blood cells and the liver in high-fat-fed rats. Ann Nutr Metab 48, 314–320 (2004).

    Article  PubMed  CAS  Google Scholar 

  258. 258. B. Mishra, K. I. Priyadarsini, M. K. Bhide, R. M. Kadam, and H. Mohan, Reactions of superoxide radicals with curcumin: Probable mechanisms by optical spectroscopy and EPR. Free Radical Res 38, 355–362 (2004).

    Article  CAS  Google Scholar 

  259. 259. R. Barreto, S. Kawakita, J. Tsuchiya, E. Minelli, K. Pavasuthipaisit, A. Helmy, and F. Marotta, Metal-induced oxidative damage in cultured hepatocytes and hepatic lysosomal fraction: beneficial effect of a curcumin/absinthium compound. Chin J Dig Dis 6, 31–36,(2005).

    Article  PubMed  CAS  Google Scholar 

  260. 260. J. Chen, D. Wanming, D. Zhang, Q. Liu, and J. Kang, Water-soluble antioxidants improve the antioxidant and anticancer activity of low concentrations of curcumin in human leukemia cells. Pharmazie 60, 57–61 (2005).

    PubMed  CAS  Google Scholar 

  261. 261. S. Durgaprasad, C. G. Pai, Vasanthkumar, J. F. Alvres, and S. Namitha, A pilot study of the antioxidant effect of curcumin in tropical pancreatitis. Indian J Med Res 122, 315–318 (2005).

    PubMed  CAS  Google Scholar 

  262. 262. V. Eybl, D. Kotyzova, L. Leseticky, M. Bludovska, and J. Koutensky, The influence of curcumin and manganese complex of curcumin on cadmium-induced oxidative damage and trace elements status in tissues of mice. J Appl Toxicol 26(3), 207–212 (2005).

    Article  CAS  Google Scholar 

  263. 263. W. M. Weber, L. A. Hunsaker, S. F. Abcouwer, L. M. Deck, and D. L. Vander Jagt, Anti-oxidant activities of curcumin and related enones. Bioorg Med Chem 13, 3811–3820 (2005).

    Article  PubMed  CAS  Google Scholar 

  264. 264. M. Sreepriya and G. Bali, Effects of administration of Embelin and Curcumin on lipid peroxidation, hepatic glutathione antioxidant defense and hematopoietic system during N-nitrosodiethylamine/Phenobarbital-induced hepatocarcinogenesis in Wistar rats. Mol Cell Biochem, 1–7 (2006).

    Google Scholar 

  265. 265. Q. Y. Wei, W. F. Chen, B. Zhou, L. Yang, and Z. L. Liu, Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues. Biochim Biophys Acta 1760, 70–77 (2006).

    PubMed  CAS  Google Scholar 

  266. 266. A. R. Shahed, E. Jones, and D. Shoskes, Quercetin and curcumin up-regulate antioxidant gene expression in rat kidney after ureteral obstruction or ischemia/reperfusion injury. Transplant Proc 33, 2988 (2001).

    Article  PubMed  CAS  Google Scholar 

  267. 267. F. Bonte, M. S. Noel-Hudson, J. Wepierre and A. Meybeck, Protective effect of curcuminoids on epidermal skin cells under free oxygen radical stress. Planta Med 63, 265–266 (1997).

    Article  PubMed  CAS  Google Scholar 

  268. 268. S. Watanabe and T. Fukui, Suppressive effect of curcumin on trichloroethylene-induced oxidative stress. J Nutr Sci Vitaminol (Tokyo) 46, 230–234 (2000).

    CAS  Google Scholar 

  269. 269. J. L. Quiles, M. D. Mesa, C. L. Ramirez-Tortosa, C. M. Aguilera, M. Battino, A. Gil and M. C. Ramirez-Tortosa, Curcuma longa extract supplementation reduces oxidative stress and attenuates aortic fatty streak development in rabbits. Arterioscler Thromb Vasc Biol 22, 1225–1231 (2002).

    Article  PubMed  CAS  Google Scholar 

  270. 270. W. H. Chan, C. C. Wu, and J. S. Yu, Curcumin inhibits UV irradiation-induced oxidative stress and apoptotic biochemical changes in human epidermoid carcinoma A431 cells. J Cell Biochem 90, 327–338 (2003).

    Article  PubMed  CAS  Google Scholar 

  271. 271. P. Mahakunakorn, M. Tohda, Y. Murakami, K. Matsumoto, H. Watanabe, and O. Vajaragupta, Cytoprotective and cytotoxic effects of curcumin: dual action on H2O2-induced oxidative cell damage in NG108-15 cells. Biol Pharm Bull 26, 725–728 (2003).

    Article  PubMed  CAS  Google Scholar 

  272. 272. R. Rukkumani, K. Aruna, P. S. Varma, K. N. Rajasekaran, and V. P. Menon, Comparative effects of curcumin and an analog of curcumin on alcohol and PUFA induced oxidative stress. J Pharm Pharm Sci 7, 274–283 (2004).

    PubMed  CAS  Google Scholar 

  273. 273. R. Banjerdpongchai and P. Wilairat, Effects of water-soluble antioxidants and MAPKK/MEK inhibitor on curcumin-induced apoptosis in HL-60 human leukemic cells. Asian Pac J Cancer Prev 6, 282–285 (2005).

    PubMed  Google Scholar 

  274. 274. Y. D. Hsuuw, C. K. Chang, W. H. Chan, and J. S. Yu, Curcumin prevents methylglyoxal-induced oxidative stress and apoptosis in mouse embryonic stem cells and blastocysts. J Cell Physiol 205, 379–386 (2005).

    Article  PubMed  CAS  Google Scholar 

  275. 275. T. Mahesh, M. S. Balasubashini, and V. P. Menon, Effect of photo-irradiated curcumin treatment against oxidative stress in streptozotocin-induced diabetic rats. J Med Food 8, 251–255 (2005).

    Article  PubMed  CAS  Google Scholar 

  276. 276. K. U. Schallreuter and H. Rokos, Turmeric (curcumin): A widely used curry ingredient, can contribute to oxidative stress in Asian patients with acute vitiligo. Indian J Dermatol Venereol Leprol 72, 57–59 (2006).

    PubMed  Google Scholar 

  277. 277. I. Chattopadhyay, U. Bandyopadhyay, K. Biswas, P. Maity, and R. K. Banerjee, Indomethacin inactivates gastric peroxidase to induce reactive-oxygen-mediated gastric mucosal injury and curcumin protects it by preventing peroxidase inactivation and scavenging reactive oxygen. Free Radical Biol Med 40, 1397–1408 (2006).

    Article  CAS  Google Scholar 

  278. 278. K. Cleary and R. F. McFeeters, Effects of oxygen and turmeric on the formation of oxidative aldehydes in fresh-pack dill pickles. J Agric Food Chem 54, 3421–3427 (2006).

    Article  PubMed  CAS  Google Scholar 

  279. 279. G. Scapagnini, C. Colombrita, M. Amadio, V. D'Agata, E. Arcelli, M. Sapienza, A. Quattrone, and V. Calabrese, Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid Redox Signal 8, 395–403 (2006).

    Article  PubMed  CAS  Google Scholar 

  280. 280. M. Yoshino, M. Haneda, M. Naruse, H. H. Htay, R. Tsubouchi, S. L. Qiao, W. H. Li, K. Murakami, and T. Yokochi, Prooxidant activity of curcumin: Copper-dependent formation of 8-hydroxy-2′-deoxyguanosine in DNA and induction of apoptotic cell death. Toxicol In Vitro 18, 783–789 (2004).

    Article  PubMed  CAS  Google Scholar 

  281. 281. T. Atsumi, S. Fujisawa, and K. Tonosaki, Relationship between intracellular ROS production and membrane mobility in curcumin- and tetrahydrocurcumin-treated human gingival fibroblasts and human submandibular gland carcinoma cells. Oral Dis 11, 236–242 (2005).

    Article  PubMed  CAS  Google Scholar 

  282. 282. S. Fujisawa and Y. Kadoma, Anti- and pro-oxidant effects of oxidized quercetin, curcumin or curcumin-related compounds with thiols or ascorbate as measured by the induction period method. In Vivo 20, 39–44 (2006).

    PubMed  CAS  Google Scholar 

  283. 283. S. Bhaumik, R. Anjum, N. Rangaraj, B. V. Pardhasaradhi, and A. Khar, Curcumin mediated apoptosis in AK-5 tumor cells involves the production of reactive oxygen intermediates. FEBS Lett 456, 311–314 (1999).

    Article  PubMed  CAS  Google Scholar 

  284. 284. J. Fang, J. Lu, and A. Holmgren, Thioredoxin reductase is irreversibly modified by curcumin: A novel molecular mechanism for its anticancer activity. J Biol Chem 280, 25,284–25,290 (2005).

    CAS  Google Scholar 

  285. 285. E. C. Herrmann and E. C. Moore, Purification of thioredoxin from rat Novikoff ascites hepatoma. J Biol Chem 248, 1219–1223 (1973).

    PubMed  CAS  Google Scholar 

  286. 286. E. C. Moore, A thioredoxin–thioredoxin reductase system from rat tumor. Biochem Biophys Res Commun 29, 264–8, (1967).

    Article  PubMed  CAS  Google Scholar 

  287. 287. K. U. Schallreuter and J. M. Wood, The activity and purification of membrane–associated thioredoxin reductase from human metastatic melanotic melanoma. Biochim Biophys Acta 967, 103–109 (1988).

    PubMed  CAS  Google Scholar 

  288. 288. J. L. Quiles, C. Aguilera, M. D. Mesa, M. C. Ramirez-Tortosa, L. Baro, and A. Gil, An ethanolic-aqueous extract of Curcuma longa decreases the susceptibility of liver microsomes and mitochondria to lipid peroxidation in atherosclerotic rabbits. Biofactors 8, 51–57 (1998).

    PubMed  CAS  Google Scholar 

  289. 289. L. M. Antunes, J. D. Darin, and L. Bianchi Nde, Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol Res 43, 145–150 (2001).

    Article  PubMed  CAS  Google Scholar 

  290. 290. A. Singh, S. P. Singh, and R. Bamezai, Postnatal modulation of hepatic biotransformation system enzymes via translactational exposure of F1 mouse pups to turmeric and curcumin. Cancer Lett 96, 87–93 (1995).

    Article  PubMed  CAS  Google Scholar 

  291. 291. S. Oetari, M. Sudibyo, J. N. Commandeur, R. Samhoedi, and N. P. Vermeulen, Effects of curcumin on cytochrome P450 and glutathione S–transferase activities in rat liver. Biochem Pharmacol 51, 39–45 (1996).

    Article  PubMed  CAS  Google Scholar 

  292. 292. A. Singh, S. P. Singh, and R. Bamezai, Effect of arecoline on the curcumin-modulated hepatic biotransformation system enzymes in lactating mice and translactationally exposed F1 pups. Nutr Cancer 25, 101–110 (1996).

    PubMed  CAS  Google Scholar 

  293. 293. M. L. van Iersel, J. P. Ploemen, M. Lo Bello, G. Federici, and P. J. van Bladeren, Interactions of alpha, beta-unsaturated aldehydes and ketones with human glutathione S-transferase P1-1. Chem Biol Interact 108, 67–78 (1997).

    Article  PubMed  Google Scholar 

  294. 294. M. Iqbal, S. D. Sharma, Y. Okazaki, M. Fujisawa, and S. Okada, Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: possible role in protection against chemical carcinogenesis and toxicity. Pharmacol Toxicol 92, 33–38 (2003).

    Article  PubMed  CAS  Google Scholar 

  295. 295. Y. Jiao, J. t. Wilkinson, E. Christine Pietsch, J. L. Buss, W. Wang, R. Planalp, F. M. Torti, and S. V. Torti, Iron chelation in the biological activity of curcumin. Free Radical Biol Med 40, 1152–1160 (2006).

    Article  CAS  Google Scholar 

  296. 296. A. C. Bharti, N. Donato, and B. B. Aggarwal, Curcumin (diferuloylmethane) inhibits constitutive and IL-6-inducible STAT3 phosphorylation in human multiple myeloma cells. J Immunol 171, 3863–3871 (2003).

    PubMed  CAS  Google Scholar 

  297. 297. R. K. Giri, V. Rajagopal, and V. K. Kalra, Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem 91, 1199–1210 (2004).

    Article  PubMed  CAS  Google Scholar 

  298. 298. D. Ranjan, C. Chen, T. D. Johnston, H. Jeon, and M. Nagabhushan, Curcumin inhibits mitogen stimulated lymphocyte proliferation, NFkappaB activation, and IL-2 signaling. J Surg Res 121, 171–177 (2004).

    Article  PubMed  CAS  Google Scholar 

  299. 299. J. L. Arbiser, N. Klauber, R. Rohan, R. van Leeuwen, M. T. Huang, C. Fisher, E. Flynn, and H. R. Byers, Curcumin is an in vivo inhibitor of angiogenesis. Mol Med 4, 376–383 (1998).

    PubMed  CAS  Google Scholar 

  300. 300. D. Thaloor, A. K. Singh, G. S. Sidhu, P. V. Prasad, H. K. Kleinman, and R. K. Maheshwari, Inhibition of angiogenic differentiation of human umbilical vein endothelial cells by curcumin. Cell Growth Differ 9, 305–312 (1998).

    PubMed  CAS  Google Scholar 

  301. 301. J. S. Shim, J. H. Kim, H. Y. Cho, Y. N. Yum, S. H. Kim, H. J. Park, B. S. Shim, S. H. Choi, and H. J. Kwon, Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin. Chem Biol 10, 695–704 (2003).

    Article  PubMed  CAS  Google Scholar 

  302. 302. P. Yoysungnoen, P. Wirachwong, P. Bhattarakosol, H. Niimi, and S. Patumraj, Antiangiogenic activity of curcumin in hepatocellular carcinoma cells implanted nude mice. Clin Hemorheol Microcirc 33, 127–135 (2005).

    PubMed  CAS  Google Scholar 

  303. 303. P. Yoysungnoen, P. Wirachwong, P. Bhattarakosol, H. Niimi, and S. Patumraj, Effects of curcumin on tumor angiogenesis and biomarkers, COX-2 and VEGF, in hepatocellular carcinoma cell-implanted nude mice. Clin Hemorheol Microcirc 34, 109–115 (2006).

    PubMed  CAS  Google Scholar 

  304. 304. A. Barik, K. I. Priyadarsini, and H. Mohan, Photophysical studies on binding of curcumin to bovine serum albumins. Photochem Photobiol 77, 597–603 (2003).

    Article  PubMed  CAS  Google Scholar 

  305. 305. F. Zsila, Z. Bikadi, and M. Simonyi, Unique, pH-dependent biphasic band shape of the visible circular dichroism of curcumin-serum albumin complex. Biochem Biophys Res Commun 301, 776–782 (2003).

    Article  PubMed  CAS  Google Scholar 

  306. 306. A. Barik, B. Mishra, L. Shen, H. Mohan, R. M. Kadam, S. Dutta, H. Y. Zhang, and K. I. Priyadarsini, Evaluation of a new copper(II)-curcumin complex as superoxide dismutase mimic and its free radical reactions. Free Radical Biol Med 39, 811–822 (2005).

    Article  CAS  Google Scholar 

  307. 307. E. Skrzypczak-Jankun, K. Zhou, N. P. McCabe, S. H. Selman, and J. Jankun, Structure of curcumin in complex with lipoxygenase and its significance in cancer. Int J Mol Med 12, 17–24 (2003).

    PubMed  CAS  Google Scholar 

  308. 308. R. S. Ramsewak, D. L. DeWitt, and M. G. Nair, Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine 7, 303–308 (2000).

    PubMed  CAS  Google Scholar 

  309. 309. A. C. Bharti, N. Donato, S. Singh, and B. B. Aggarwal, Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor-kappa B and IkappaBalpha kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of apoptosis. Blood 101, 1053–1062 (2003).

    Article  PubMed  CAS  Google Scholar 

  310. 310. N. Romiti, R. Tongiani, F. Cervelli, and E. Chieli, Effects of curcumin on P-glycoprotein in primary cultures of rat hepatocytes. Life Sci 62, 2349–2358 (1998).

    Article  PubMed  CAS  Google Scholar 

  311. 311. S. Anuchapreeda, P. Leechanachai, M. M. Smith, S. V. Ambudkar, and P. N. Limtrakul, Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells. Biochem Pharmacol 64, 573–582 (2002).

    Article  PubMed  CAS  Google Scholar 

  312. 312. R. D. Snyder and M. R. Arnone, Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay. Mutat Res 503, 21–35 (2002).

    PubMed  CAS  Google Scholar 

  313. 313. J. L. Dyer, S. Z. Khan, J. G. Bilmen, S. R. Hawtin, M. Wheatley, M. U. Javed, and F. Michelangeli, Curcumin: a new cell-permeant inhibitor of the inositol 1,4,5-trisphosphate receptor. Cell Calcium 31, 45–52 (2002).

    Article  PubMed  CAS  Google Scholar 

  314. 314. R. R. Satoskar, S. J. Shah, and S. G. Shenoy, Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Ther Toxicol 24, 651–654 (1986).

    PubMed  CAS  Google Scholar 

  315. 315. G. J. Kelloff, C. W. Boone, J. A. Crowell, V. E. Steele, R. Lubet, and C. C. Sigman, Chemopreventive drug development: perspectives and progress. Cancer Epidemiol Biomarkers Prev 3, 85–98 (1994).

    PubMed  CAS  Google Scholar 

  316. 316. J. S. James, Curcumin: Clinical trial finds no antiviral effect. AIDS Treat News (no. 242), 1–2 (1996).

    Google Scholar 

  317. 317. G. Shoba, D. Joy, T. Joseph, M. Majeed, R. Rajendran, and P. S. Srinivas, Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 64, 353–356,(1998).

    Article  PubMed  CAS  Google Scholar 

  318. 318. B. Lal, A. K. Kapoor, O. P. Asthana, P. K. Agrawal, R. Prasad, P. Kumar, and R. C. Srimal, Efficacy of curcumin in the management of chronic anterior uveitis. Phytother Res 13, 318–322 (1999).

    Article  PubMed  CAS  Google Scholar 

  319. 319. A. Rasyid and A. Lelo, The effect of curcumin and placebo on human gall-bladder function: an ultrasound study. Aliment Pharmacol Ther 13, 245–249,(1999).

    Article  PubMed  CAS  Google Scholar 

  320. 320. M. C. Heng, M. K. Song, J. Harker, and M. K. Heng, Drug-induced suppression of phosphorylase kinase activity correlates with resolution of psoriasis as assessed by clinical, histological and immunohistochemical parameters. Br J Dermatol 143, 937–049 (2000).

    Article  PubMed  CAS  Google Scholar 

  321. 321. R. Lodha and A. Bagga, Traditional Indian systems of medicine. Ann Acad Med Singapore 29, 37–41 (2000).

    PubMed  CAS  Google Scholar 

  322. 322. A. L. Cheng, C. H. Hsu, J. K. Lin, M. M. Hsu, Y. F. Ho, T. S. Shen, J. Y. Ko, J. T. Lin, B. R. Lin, W. Ming-Shiang, H. S. Yu, S. H. Jee, G. S. Chen, T. M. Chen, C. A. Chen, M. K. Lai, Y. S. Pu, M. H. Pan, Y. J. Wang, C. C. Tsai, and C. Y. Hsieh, Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21, 2895–2900 (2001).

    PubMed  CAS  Google Scholar 

  323. 323. S. M. Plummer, K. A. Hill, M. F. Festing, W. P. Steward, A. J. Gescher, and R. A. Sharma, Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents. Cancer Epidemiol Biomarkers Prev 10, 1295–1299 (2001).

    PubMed  CAS  Google Scholar 

  324. 324. R. A. Sharma, H. R. McLelland, K. A. Hill, C. R. Ireson, S. A. Euden, M. M. Manson, M. Pirmohamed, L. J. Marnett, A. J. Gescher, and W. P. Steward, Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7, 1894–1900 (2001).

    PubMed  CAS  Google Scholar 

  325. 325. A. Rasyid, A. R. Rahman, K. Jaalam, and A. Lelo, Effect of different curcumin dosages on human gall bladder. Asia Pacific J Clin Nutr 11, 314–318 (2002).

    Article  CAS  Google Scholar 

  326. 326. M. Bayes, X. Rabasseda, and J. R. Prous, Gateways to clinical trials. Methods Find Exp Clin Pharmacol 26, 723–753 (2004).

    PubMed  CAS  Google Scholar 

  327. 327. G. M. Cole, T. Morihara, G. P. Lim, F. Yang, A. Begum, and S. A. Frautschy, NSAID and antioxidant prevention of Alzheimer's disease: Lessons from in vitro and animal models. Ann N Y Acad Sci 1035, 68–84 (2004).

    Article  PubMed  CAS  Google Scholar 

  328. 328. G. Garcea, D. J. Jones, R. Singh, A. R. Dennison, P. B. Farmer, R. A. Sharma, W. P. Steward, A. J. Gescher, and D. P. Berry, Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer 90, 1011–1015 (2004).

    Article  PubMed  CAS  Google Scholar 

  329. 329. R. A. Sharma, S. A. Euden, S. L. Platton, D. N. Cooke, A. Shafayat, H. R. Hewitt, T. H. Marczylo, B. Morgan, D. Hemingway, S. M. Plummer, M. Pirmohamed, A. J. Gescher, and W. P. Steward, Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10, 6847–6854 (2004).

    Article  PubMed  CAS  Google Scholar 

  330. 330. M. Bayes, X. Rabasseda, and J. R. Prous, Gateways to clinical trials. Methods Find Exp Clin Pharmacol 27, 711–738 (2005).

    PubMed  CAS  Google Scholar 

  331. 331. G. Garcea, D. P. Berry, D. J. Jones, R. Singh, A. R. Dennison, P. B. Farmer, R. A. Sharma, W. P. Steward, and A. J. Gescher, Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev 14, 120–125 (2005).

    PubMed  CAS  Google Scholar 

  332. 332. P. R. Holt, S. Katz, and R. Kirshoff, Curcumin therapy in inflammatory bowel disease: A pilot study. Dig Dis Sci 50, 2191–2193 (2005).

    Article  PubMed  Google Scholar 

  333. 333. D. Shoskes, C. Lapierre, M. Cruz-Corerra, N. Muruve, R. Rosario, B. Fromkin, M. Braun, and J. Copley, Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: A randomized placebo controlled trial. Transplantation 80, 1556–1559 (2005).

    Article  PubMed  CAS  Google Scholar 

  334. 334. C. D. Lao, M. T. t. Ruffin, D. Normolle, D. D. Heath, S. I. Murray, J. M. Bailey, M. E. Boggs, J. Crowell, C. L. Rock, and D. E. Brenner, Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6, 10 (2006).

    Article  PubMed  CAS  Google Scholar 

  335. 335. M. Cruz-Correa, D. A. Shoskes, P. Sanchez, R. Zhao, L. M. Hylind, S. D. Wexner, and F. M. Giardiello, Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol 4, 1035–1038 (2006).

    Article  PubMed  CAS  Google Scholar 

  336. 336. I. Gukovsky, C. N. Reyes, E. C. Vaquero, A. S. Gukovskaya, and S. J. Pandol, Curcumin ameliorates ethanol and nonethanol experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol 284, G85–G9, (2003).

    PubMed  CAS  Google Scholar 

  337. 337. A. Gulcubuk, K. Sonmez, A. Gurel, K. Altunatmaz, N. Gurler, S. Aydin, L. Oksuz, H. Uzun, and O. Guzel, Pathologic alterations detected in acute pancreatitis induced by sodium taurocholate in rats and therapeutic effects of curcumin, ciprofloxacin and metronidazole combination. Pancreatology 5, 345–353 (2005).

    Article  PubMed  CAS  Google Scholar 

  338. 338. B. Joe, U. J. Rao, and B. R. Lokesh, Presence of an acidic glycoprotein in the serum of arthritic rats: modulation by capsaicin and curcumin. Mol Cell Biochem 169, 125–134 (1997).

    Article  PubMed  CAS  Google Scholar 

  339. 339. A. Liacini, J. Sylvester, W. Q. Li, and M. Zafarullah, Inhibition of interleukin-1-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 21, 251–262 (2002).

    Article  PubMed  CAS  Google Scholar 

  340. 340. A. Liacini, J. Sylvester, W. Q. Li, W. Huang, F. Dehnade, M. Ahmad, and M. Zafarullah, Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res 288, 208–217 (2003).

    Article  PubMed  CAS  Google Scholar 

  341. 341. J. Sylvester, A. Liacini, W. Q. Li, and M. Zafarullah, Interleukin-17 signal transduction pathways implicated in inducing matrix metalloproteinase-3, -13 and aggrecanase-1 genes in articular chondrocytes. Cell Signal 16, 469–476 (2004).

    Article  PubMed  CAS  Google Scholar 

  342. 342. K. Sugimoto, H. Hanai, K. Tozawa, T. Aoshi, M. Uchijima, T. Nagata, and Y. Koide, Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology 123, 1912–1922 (2002).

    Article  PubMed  CAS  Google Scholar 

  343. 343. B. Salh, K. Assi, V. Templeman, K. Parhar, D. Owen, A. Gomez-Munoz, and K. Jacobson, Curcumin attenuates DNB-induced murine colitis. Am J Physiol Gastrointest Liver Physiol 285, G235–G243 (2003).

    PubMed  CAS  Google Scholar 

  344. 344. Y. Jiang, Z. S. Li, F. S. Jiang, X. Deng, C. S. Yao, and G. Nie, Effects of different ingredients of zedoary on gene expression of HSC-T6 cells. World J Gastroenterol 11, 6780–6786 (2005).

    PubMed  CAS  Google Scholar 

  345. 345. D. C. Kim, S. H. Kim, B. H. Choi, N. I. Baek, D. Kim, M. J. Kim, and K. T. Kim, Curcuma longa extract protects against gastric ulcers by blocking H2 histamine receptors. Biol Pharm Bull 28, 2220–2224 (2005).

    Article  PubMed  CAS  Google Scholar 

  346. 346. S. Swarnakar, K. Ganguly, P. Kundu, A. Banerjee, P. Maity, and A. V. Sharma, Curcumin regulates expression and activity of matrix metalloproteinases 9 and 2 during prevention and healing of indomethacin-induced gastric ulcer. J Biol Chem 280, 9409–9415 (2005).

    Article  PubMed  CAS  Google Scholar 

  347. 347. O. S. Baek, O. H. Kang, Y. A. Choi, S. C. Choi, T. H. Kim, Y. H. Nah, D. Y. Kwon, Y. K. Kim, Y. H. Kim, K. H. Bae, J. P. Lim, and Y. M. Lee, Curcumin inhibits protease-activated receptor-2 and -4-mediated mast cell activation. Clin Chim Acta 338, 135–141 (2003).

    Article  PubMed  CAS  Google Scholar 

  348. 348. A. Ram, M. Das, and B. Ghosh, Curcumin attenuates allergen-induced airway hyperresponsiveness in sensitized guinea pigs. Biol Pharm Bull 26, 1021–1024 (2003).

    Article  PubMed  CAS  Google Scholar 

  349. 349. J. J. Lee, W. T. Huang, D. Z. Shao, J. F. Liao, and M. T. Lin, Blocking NF-kappaB activation may be an effective strategy in the fever therapy. Jpn J Physiol 53, 367–375 (2003).

    Article  PubMed  CAS  Google Scholar 

  350. 350. D. Z. Shao, J. J. Lee, W. T. Huang, J. F. Liao, and M. T. Lin, Inhibition of nuclear factor-kappa B prevents staphylococcal enterotoxin A-induced fever. Mol Cell Biochem 262, 177–185 (2004).

    Article  PubMed  CAS  Google Scholar 

  351. 351. E. Tourkina, P. Gooz, J. C. Oates, A. Ludwicka-Bradley, R. M. Silver, and S. Hoffman, Curcumin-induced apoptosis in scleroderma lung fibroblasts: role of protein kinase cepsilon. Am J Respir Cell Mol Biol 31, 28–35 (2004).

    Article  PubMed  CAS  Google Scholar 

  352. 352. B. Bosman, Testing of lipoxygenase inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis. Skin Pharmacol 7, 324–334 (1994).

    PubMed  CAS  Google Scholar 

  353. 353. R. Verbeek, E. A. van Tol, and J. M. van Noort, Oral flavonoids delay recovery from experimental autoimmune encephalomyelitis in SJL mice. Biochem Pharmacol 70, 220–228 (2005).

    Article  PubMed  CAS  Google Scholar 

  354. 354. P. S. Babu and K. Srinivasan, Influence of dietary curcumin and cholesterol on the progression of experimentally induced diabetes in albino rat. Mol Cell Biochem 152, 13–21 (1995).

    PubMed  CAS  Google Scholar 

  355. 355. P. S. Babu and K. Srinivasan, Hypolipidemic action of curcumin, the active principle of turmeric (Curcuma longa) in streptozotocin induced diabetic rats. Mol Cell Biochem 166, 169–175 (1997).

    Article  PubMed  CAS  Google Scholar 

  356. 356. G. B. Sajithlal, P. Chithra, and G. Chandrakasan, Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmacol 56, 1607–1614 (1998).

    Article  PubMed  CAS  Google Scholar 

  357. 357. N. Arun and N. Nalini, Efficacy of turmeric on blood sugar and polyol pathway in diabetic albino rats. Plant Foods Hum Nutr 57, 41–52 (2002).

    Article  PubMed  CAS  Google Scholar 

  358. 358. R. K. Kempaiah and K. Srinivasan, Antioxidant status of red blood cells and liver in hypercholesterolemic rats fed hypolipidemic spices. Int J Vitam Nutr Res 74, 199–208 (2004).

    Article  PubMed  CAS  Google Scholar 

  359. 359. T. Mahesh, M. M. Sri Balasubashini, and V. P. Menon, Photo-irradiated curcumin supplementation in streptozotocin-induced diabetic rats: effect on lipid peroxidation. Therapie 59, 639–644 (2004).

    Article  PubMed  Google Scholar 

  360. 360. M. Kuroda, Y. Mimaki, T. Nishiyama, T. Mae, H. Kishida, M. Tsukagawa, K. Takahashi, T. Kawada, K. Nakagawa, and M. Kitahara, Hypoglycemic effects of turmeric (Curcuma longa L. rhizomes) on genetically diabetic KK-Ay mice. Biol Pharm Bull 28, 937–939 (2005).

    Article  PubMed  CAS  Google Scholar 

  361. 361. J. B. Majithiya and R. Balaraman, Time-dependent changes in antioxidant enzymes and vascular reactivity of aorta in streptozotocin-induced diabetic rats treated with curcumin. J Cardiovasc Pharmacol 46, 697–705 (2005).

    Article  PubMed  CAS  Google Scholar 

  362. 362. T. Osawa and Y. Kato, Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann NY Acad Sci 1043, 440–451 (2005).

    Article  PubMed  CAS  Google Scholar 

  363. 363. B. B. Aggarwal, Y. Takada, and O. V. Oommen, From chemoprevention to chemotherapy: Common targets and common goals. Expert Opin Invest Drugs 13, 1327–1338 (2004).

    Article  CAS  Google Scholar 

  364. 364. J. L. Abbruzzese and S. M. Lippman, The convergence of cancer prevention and therapy in early-phase clinical drug development. Cancer Cell 6, 321–326 (2004).

    Article  PubMed  CAS  Google Scholar 

  365. 365. H. Inano, M. Onoda, N. Inafuku, M. Kubota, Y. Kamada, T. Osawa, H. Kobayashi, and K. Wakabayashi, Potent preventive action of curcumin on radiation-induced initiation of mammary tumorigenesis in rats. Carcinogenesis 21, 1835–1841 (2000).

    Article  PubMed  CAS  Google Scholar 

  366. 366. S. E. Chuang, M. L. Kuo, C. H. Hsu, C. R. Chen, J. K. Lin, G. M. Lai, C. Y. Hsieh, and A. L. Cheng, Curcumin-containing diet inhibits diethylnitrosamine-induced murine hepatocarcinogenesis. Carcinogenesis 21, 331–335 (2000).

    Article  PubMed  CAS  Google Scholar 

  367. 367. S. E. Chuang, A. L. Cheng, J. K. Lin, and M. L. Kuo, Inhibition by curcumin of diethylnitrosamine-induced hepatic hyperplasia, inflammation, cellular gene products and cell-cycle-related proteins in rats. Food Chem Toxicol 38, 991–995 (2000).

    Article  PubMed  CAS  Google Scholar 

  368. 368. C. C. Chua, R. C. Hamdy, and B. H. Chua, Mechanism of transforming growth factor-beta1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells. Biochim Biophys Acta 1497, 69–76 (2000).

    Article  PubMed  CAS  Google Scholar 

  369. 369. Y. Shukla and A. Arora, Suppression of altered hepatic foci development by curcumin in wistar rats. Nutr Cancer 45, 53–59 (2003).

    Article  PubMed  CAS  Google Scholar 

  370. 370. M. Sreepriya and G. Bali, Chemopreventive effects of embelin and curcumin against N-nitrosodiethylamine/phenobarbital-induced hepatocarcinogenesis in Wistar rats. Fitoterapia 76, 549–555 (2005).

    Article  PubMed  CAS  Google Scholar 

  371. 371. M. C. Jiang, H. F. Yang-Yen, J. K. Lin, and J. J. Yen, Differential regulation of p53, c-Myc, Bcl-2 and Bax protein expression during apoptosis induced by widely divergent stimuli in human hepatoblastoma cells. Oncogene 13, 609–616 (1996).

    PubMed  CAS  Google Scholar 

  372. 372. K. Imaida, S. Tamano, K. Kato, Y. Ikeda, M. Asamoto, S. Takahashi, Z. Nir, M. Murakoshi, H. Nishino, and T. Shirai, Lack of chemopreventive effects of lycopene and curcumin on experimental rat prostate carcinogenesis. Carcinogenesis 22, 467–472 (2001).

    Article  PubMed  CAS  Google Scholar 

  373. 373. M. L. Kuo, T. S. Huang, and J. K. Lin, Curcumin, an antioxidant and anti-tumor promoter, induces apoptosis in human leukemia cells. Biochim Biophys Acta 1317, 95–100 (1996).

    PubMed  CAS  Google Scholar 

  374. 374. Y. Wu, Y. Chen, and W. Chen, Effects of concurrent use of rh-IFN-gamma and curcumin on the anti-proliferative capacity of HL-60 cells. J Tongji Med Univ 19, 267–270 (1999).

    Article  PubMed  CAS  Google Scholar 

  375. 375. A. Bielak-Zmijewska, M. Koronkiewicz, J. Skierski, K. Piwocka, E. Radziszewska, and E. Sikora, Effect of curcumin on the apoptosis of rodent and human nonproliferating and proliferating lymphoid cells. Nutr Cancer 38, 131–138 (2000).

    Article  PubMed  CAS  Google Scholar 

  376. 376. Y. Chen, Y. Wu, J. He, and W. Chen, The experimental and clinical study on the effect of curcumin on cell cycle proteins and regulating proteins of apoptosis in acute myelogenous leukemia. J Huazhong Univ Sci Technol Med Sci 22, 295–298 (2002).

    Article  PubMed  CAS  Google Scholar 

  377. 377. A. Duvoix, F. Morceau, M. Schnekenburger, S. Delhalle, M. M. Galteau, M. Dicato, and M. Diederich, Curcumin-induced cell death in two leukemia cell lines: K562 and Jurkat. Ann NY Acad Sci 1010, 389–392 (2003).

    Article  PubMed  CAS  Google Scholar 

  378. 378. L. X. Wu, J. H. Xu, G. H. Wu, and Y. Z. Chen, Inhibitory effect of curcumin on proliferation of K562 cells involves down-regulation of p210(bcr/abl) initiated Ras signal transduction pathway. Acta Pharmacol Sin 24, 1155–1160 (2003).

    PubMed  CAS  Google Scholar 

  379. 379. A. Bielak-Mijewska, K. Piwocka, A. Magalska, and E. Sikora, P-glycoprotein expression does not change the apoptotic pathway induced by curcumin in HL-60 cells. Cancer Chemother Pharmacol 53, 179–185 (2004).

    Article  PubMed  CAS  Google Scholar 

  380. 380. E. Sikora, A. Bielak-Zmijewska, K. Piwocka, J. Skierski, and E. Radziszewska, Inhibition of proliferation and apoptosis of human and rat T lymphocytes by curcumin, a curry pigment. Biochem Pharmacol 54, 899–907 (1997).

    Article  PubMed  CAS  Google Scholar 

  381. 381. K. Piwocka, K. Zablocki, M. R. Wieckowski, J. Skierski, I. Feiga, J. Szopa, N. Drela, L. Wojtczak, and E. Sikora, A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by curcumin in human lymphoblastoid T (Jurkat) cells. Exp Cell Res 249, 299–307 (1999).

    Article  PubMed  CAS  Google Scholar 

  382. 382. E. Jaruga, S. Salvioli, J. Dobrucki, S. Chrul, J. Bandorowicz-Pikula, E. Sikora, C. Franceschi, A. Cossarizza, and G. Bartosz, Apoptosis-like, reversible changes in plasma membrane asymmetry and permeability, and transient modifications in mitochondrial membrane potential induced by curcumin in rat thymocytes. FEBS Lett 433, 287–293 (1998).

    Article  PubMed  CAS  Google Scholar 

  383. 383. D. Ranjan, T. D. Johnston, K. S. Reddy, G. Wu, S. Bondada, and C. Chen, Enhanced apoptosis mediates inhibition of EBV-transformed lymphoblastoid cell line proliferation by curcumin. J Surg Res 87, 1–5 (1999).

    Article  PubMed  CAS  Google Scholar 

  384. 384. H. L. Liu, Y. Chen, G. H. Cui, and J. F. Zhou, Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation. Acta Pharmacol Sin 26, 603–609 (2005).

    Article  PubMed  CAS  Google Scholar 

  385. 385. S. Shishodia, G. Sethi, and B. B. Aggarwal, Curcumin: Getting back to the roots. Ann NY Acad Sci 1056, 206–217 (2005).

    Article  PubMed  CAS  Google Scholar 

  386. 386. C. Sun, X. Liu, Y. Chen, and F. Liu, Anticancer effect of curcumin on human B cell non-Hodgkin's lymphoma. J Huazhong Univ Sci Technolog Med Sci 25, 404–407 (2005).

    Article  PubMed  CAS  Google Scholar 

  387. 387. Y. Wu, Y. Chen, J. Xu, and L. Lu, Anticancer activities of curcumin on human Burkitt's lymphoma. Zhonghua Zhong Liu Za Zhi 24, 348–352 (2002).

    PubMed  Google Scholar 

  388. 388. A. C. Bharti, S. Shishodia, J. M. Reuben, D. Weber, R. Alexanian, S. Raj-Vadhan, Z. Estrov, M. Talpaz, and B. B. Aggarwal, Nuclear factor-kappaB and STAT3 are constitutively active in CD138+ cells derived from multiple myeloma patients, and suppression of these transcription factors leads to apoptosis. Blood 103, 3175–3184 (2004).

    Article  PubMed  CAS  Google Scholar 

  389. 389. S. Uddin, A. R. Hussain, P. S. Manogaran, K. Al-Hussein, L. C. Platanias, M. I. Gutierrez, and K. G. Bhatia, Curcumin suppresses growth and induces apoptosis in primary effusion lymphoma. Oncogene 24, 7022–7030 (2005).

    Article  PubMed  CAS  Google Scholar 

  390. 390. N. R. Jana, P. Dikshit, A. Goswami, and N. Nukina, Inhibition of proteasomal function by curcumin induces apoptosis through mitochondrial pathway. J Biol Chem 279, 11,680–11,685 (2004).

    CAS  Google Scholar 

  391. 391. A. Liontas and H. Yeger, Curcumin and resveratrol induce apoptosis and nuclear translocation and activation of p53 in human neuroblastoma. Anticancer Res 24, 987–998 (2004).

    PubMed  CAS  Google Scholar 

  392. 392. M. H. Pan, W. L. Chang, S. Y. Lin-Shiau, C. T. Ho, and J. K. Lin, Induction of apoptosis by garcinol and curcumin through cytochrome c release and activation of caspases in human leukemia HL-60 cells. J Agric Food Chem 49, 1464–1474 (2001).

    Article  PubMed  CAS  Google Scholar 

  393. 393. S. Nagai, M. Kurimoto, K. Washiyama, Y. Hirashima, T. Kumanishi, and S. Endo, Inhibition of cellular proliferation and induction of apoptosis by curcumin in human malignant astrocytoma cell lines. J Neurooncol 74, 105–111 (2005).

    Article  PubMed  CAS  Google Scholar 

  394. 394. K. Mehta, P. Pantazis, T. McQueen, and B. B. Aggarwal, Antiproliferative effect of curcumin (diferuloylmethane) against human breast tumor cell lines. Anticancer Drugs 8, 470–481 (1997).

    Article  PubMed  CAS  Google Scholar 

  395. 395. C. Ramachandran and W. You, Differential sensitivity of human mammary epithelial and breast carcinoma cell lines to curcumin. Breast Cancer Res Treat 54, 269–278 (1999).

    Article  PubMed  CAS  Google Scholar 

  396. 396. T. Choudhuri, S. Pal, M. L. Agwarwal, T. Das, and G. Sa, Curcumin induces apoptosis in human breast cancer cells through p53-dependent Bax induction. FEBS Lett 512, 334–340 (2002).

    Article  PubMed  CAS  Google Scholar 

  397. 397. J. M. Holy, Curcumin disrupts mitotic spindle structure and induces micronucleation in MCF-7 breast cancer cells. Mutat Res 518, 71–84 (2002).

    PubMed  CAS  Google Scholar 

  398. 398. Z. M. Shao, Z. Z. Shen, C. H. Liu, M. R. Sartippour, V. L. Go, D. Heber, and M. Nguyen, Curcumin exerts multiple suppressive effects on human breast carcinoma cells. Int J Cancer 98, 234–240 (2002).

    Article  PubMed  CAS  Google Scholar 

  399. 399. C. Ramachandran, S. Rodriguez, R. Ramachandran, P. K. Raveendran Nair, H. Fonseca, Z. Khatib, E. Escalon, and S. J. Melnick, Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res 25, 3293–3302 (2005).

    PubMed  CAS  Google Scholar 

  400. 400. L. Moragoda, R. Jaszewski, and A. P. Majumdar, Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells. Anticancer Res 21, 873–878 (2001).

    PubMed  CAS  Google Scholar 

  401. 401. S. Aggarwal, Y. Takada, S. Singh, J. N. Myers, and B. B. Aggarwal, Inhibition of growth and survival of human head and neck squamous cell carcinoma cells by curcumin via modulation of nuclear factor-kappaB signaling. Int J Cancer 111, 679–692 (2004).

    Article  PubMed  CAS  Google Scholar 

  402. 402. G. Radhakrishna Pillai, A. S. Srivastava, T. I. Hassanein, D. P. Chauhan, and E. Carrier, Induction of apoptosis in human lung cancer cells by curcumin. Cancer Lett 208, 163–170 (2004).

    Article  PubMed  CAS  Google Scholar 

  403. 403. L. Li, B. B. Aggarwal, S. Shishodia, J. Abbruzzese, and R. Kurzrock, Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis. Cancer 101, 2351–2362 (2004).

    Article  PubMed  CAS  Google Scholar 

  404. 404. M. Shi, Q. Cai, L. Yao, Y. Mao, Y. Ming, and G. Ouyang, Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol Int 30, 221–226 (2006).

    Article  PubMed  CAS  Google Scholar 

  405. 405. R. Kuttan, P. C. Sudheeran, and C. D. Josph, Turmeric and curcumin as topical agents in cancer therapy. Tumori 73, 29–31 (1987).

    PubMed  CAS  Google Scholar 

  406. 406. M. A. Azuine and S. V. Bhide, Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr Cancer 17, 77–83 (1992).

    PubMed  CAS  Google Scholar 

  407. 407. M. T. Huang, E. E. Deschner, H. L. Newmark, Z. Y. Wang, T. A. Ferraro, and A. H. Conney, Effect of dietary curcumin and ascorbyl palmitate on azoxymethanol-induced colonic epithelial cell proliferation and focal areas of dysplasia. Cancer Lett 64, 117–121 (1992).

    Article  PubMed  CAS  Google Scholar 

  408. 408. M. T. Huang, Z. Y. Wang, C. A. Georgiadis, J. D. Laskin, and A. H. Conney, Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. Carcinogenesis 13, 2183–2186 (1992).

    Article  PubMed  CAS  Google Scholar 

  409. 409. M. T. Huang, W. Ma, P. Yen, J. G. Xie, J. Han, K. Frenkel, D. Grunberger, and A. H. Conney, Inhibitory effects of topical application of low doses of curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion and oxidized DNA bases in mouse epidermis. Carcinogenesis 18, 83–88 (1997).

    Article  PubMed  CAS  Google Scholar 

  410. 410. P. Limtrakul, S. Lipigorngoson, O. Namwong, A. Apisariyakul, and F. W. Dunn, Inhibitory effect of dietary curcumin on skin carcinogenesis in mice. Cancer Lett 116, 197–203 (1997).

    Article  PubMed  CAS  Google Scholar 

  411. 411. M. C. Jiang, H. F. Yang-Yen, J. J. Yen, and J. K. Lin, Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines. Nutr Cancer 26, 111–120 (1996).

    PubMed  CAS  Google Scholar 

  412. 412. J. A. Bush, K. J. Cheung, Jr., and G. Li, Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53. Exp Cell Res 271, 305–314 (2001).

    Article  PubMed  CAS  Google Scholar 

  413. 413. M. Zheng, S. Ekmekcioglu, E. T. Walch, C. H. Tang, and E. A. Grimm, Inhibition of nuclear factor-kappaB and nitric oxide by curcumin induces G2/M cell cycle arrest and apoptosis in human melanoma cells. Melanoma Res 14, 165–171 (2004).

    Article  PubMed  CAS  Google Scholar 

  414. 414. D. R. Siwak, S. Shishodia, B. B. Aggarwal, and R. Kurzrock, Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of IkappaB kinase and nuclear factor kappaB activity and are independent of the B-Raf/mitogen-activated/extracellular signal-regulated protein kinase pathway and the Akt pathway. Cancer 104, 879–890 (2005).

    Article  PubMed  CAS  Google Scholar 

  415. 415. W. H. Chan and H. J. Wu, Anti-apoptotic effects of curcumin on photosensitized human epidermal carcinoma A431 cells. J Cell Biochem 92, 200–212 (2004).

    Article  PubMed  CAS  Google Scholar 

  416. 416. M. A. Azuine and S. V. Bhide, Adjuvant chemoprevention of experimental cancer: Catechin and dietary turmeric in forestomach and oral cancer models. J Ethnopharmacol 44, 211–217 (1994).

    Article  PubMed  CAS  Google Scholar 

  417. 417. T. Tanaka, H. Makita, M. Ohnishi, Y. Hirose, A. Wang, H. Mori, K. Satoh, A. Hara, and H. Ogawa, Chemoprevention of 4-nitroquinoline 1-oxide-induced oral carcinogenesis by dietary curcumin and hesperidin: comparison with the protective effect of beta-carotene. Cancer Res 54, 4653–4659 (1994).

    PubMed  CAS  Google Scholar 

  418. 418. K. Krishnaswamy, V. K. Goud, B. Sesikeran, M. A. Mukundan, and T. P. Krishna, Retardation of experimental tumorigenesis and reduction in DNA adducts by turmeric and curcumin. Nutr Cancer 30, 163–166 (1998).

    PubMed  CAS  Google Scholar 

  419. 419. N. Li, X. Chen, J. Liao, G. Yang, S. Wang, Y. Josephson, C. Han, J. Chen, M. T. Huang, and C. S. Yang, Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced oral carcinogenesis in hamsters by tea and curcumin. Carcinogenesis 23, 1307–1313 (2002).

    Article  PubMed  CAS  Google Scholar 

  420. 420. N. Li, X. Chen, C. Han, and J. Chen, [Chemopreventive effect of tea and curcumin on DMBA-induced oral carcinogenesis in hamsters]. Wei Sheng Yan Jiu 31, 354–357 (2002).

    PubMed  CAS  Google Scholar 

  421. 421. J. Ushida, S. Sugie, K. Kawabata, Q. V. Pham, T. Tanaka, K. Fujii, H. Takeuchi, Y. Ito, and H. Mori, Chemopreventive effect of curcumin on N-nitrosomethylbenzylamine-induced esophageal carcinogenesis in rats. Jpn J Cancer Res 91, 893–898 (2000).

    PubMed  CAS  Google Scholar 

  422. 422. M. T. Huang, Y. R. Lou, W. Ma, H. L. Newmark, K. R. Reuhl, and A. H. Conney, Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res 54, 5841–5847 (1994).

    PubMed  CAS  Google Scholar 

  423. 423. S. V. Singh, X. Hu, S. K. Srivastava, M. Singh, H. Xia, J. L. Orchard, and H. A. Zaren, Mechanism of inhibition of benzo[a]pyrene-induced forestomach cancer in mice by dietary curcumin. Carcinogenesis 19, 1357–1360 (1998).

    Article  PubMed  CAS  Google Scholar 

  424. 424. S. Ikezaki, A. Nishikawa, F. Furukawa, K. Kudo, H. Nakamura, K. Tamura, and H. Mori, Chemopreventive effects of curcumin on glandular stomach carcinogenesis induced by N-methyl-N′-nitro-N-nitrosoguanidine and sodium chloride in rats. Anticancer Res 21, 3407–3411 (2001).

    PubMed  CAS  Google Scholar 

  425. 425. S. Perkins, R. D. Verschoyle, K. Hill, I. Parveen, M. D. Threadgill, R. A. Sharma, M. L. Williams, W. P. Steward, and A. J. Gescher, Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev 11, 535–540 (2002).

    PubMed  CAS  Google Scholar 

  426. 426. S. Perkins, A. R. Clarke, W. Steward, and A. Gescher, Age-related difference in susceptibility of Apc(Min/+) mice towards the chemopreventive efficacy of dietary aspirin and curcumin. Br J Cancer 88, 1480–1483 (2003).

    Article  PubMed  CAS  Google Scholar 

  427. 427. M. A. Pereira, C. J. Grubbs, L. H. Barnes, H. Li, G. R. Olson, I. Eto, M. Juliana, L. M. Whitaker, G. J. Kelloff, V. E. Steele, and R. A. Lubet, Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 17, 1305–1311 (1996).

    Article  PubMed  CAS  Google Scholar 

  428. 428. M. J. Wargovich, C. D. Chen, A. Jimenez, V. E. Steele, M. Velasco, L. C. Stephens, R. Price, K. Gray, and G. J. Kelloff, Aberrant crypts as a biomarker for colon cancer: evaluation of potential chemopreventive agents in the rat. Cancer Epidemiol Biomarkers Prev 5, 355–360 (1996).

    PubMed  CAS  Google Scholar 

  429. 429. H. S. Samaha, G. J. Kelloff, V. Steele, C. V. Rao, and B. S. Reddy, Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res 57, 1301–1305 (1997).

    PubMed  CAS  Google Scholar 

  430. 430. T. Kawamori, R. Lubet, V. E. Steele, G. J. Kelloff, R. B. Kaskey, C. V. Rao, and B. S. Reddy, Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 59, 597–601 (1999).

    PubMed  CAS  Google Scholar 

  431. 431. C. V. Rao, T. Kawamori, R. Hamid, and B. S. Reddy, Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis 20, 641–644 (1999).

    Article  PubMed  CAS  Google Scholar 

  432. 432. Y. Kwon, M. Malik, and B. A. Magnuson, Inhibition of colonic aberrant crypt foci by curcumin in rats is affected by age. Nutr Cancer 48, 37–43 (2004).

    Article  PubMed  CAS  Google Scholar 

  433. 433. S. R. Volate, D. M. Davenport, S. J. Muga, and M. J. Wargovich, Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis 26, 1450–1456 (2005).

    Article  PubMed  CAS  Google Scholar 

  434. 434. J. M. Kim, S. Araki, D. J. Kim, C. B. Park, N. Takasuka, H. Baba-Toriyama, T. Ota, Z. Nir, F. Khachik, N. Shimidzu, Y. Tanaka, T. Osawa, T. Uraji, M. Murakoshi, H. Nishino, and H. Tsuda, Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis 19, 81–85 (1998).

    Article  PubMed  CAS  Google Scholar 

  435. 435. R. Hanif, L. Qiao, S. J. Shiff, and B. Rigas, Curcumin, a natural plant phenolic food additive, inhibits cell proliferation and induces cell cycle changes in colon adenocarcinoma cell lines by a prostaglandin-independent pathway. J Lab Clin Med 130, 576–584 (1997).

    Article  PubMed  CAS  Google Scholar 

  436. 436. H. Chen, Z. S. Zhang, Y. L. Zhang, and D. Y. Zhou, Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells. Anticancer Res 19, 3675–3680 (1999).

    PubMed  CAS  Google Scholar 

  437. 437. R. Rashmi, T. R. Santhosh Kumar, and D. Karunagaran, Human colon cancer cells differ in their sensitivity to curcumin-induced apoptosis and heat shock protects them by inhibiting the release of apoptosis-inducing factor and caspases. FEBS Lett 538, 19–24 (2003).

    Article  PubMed  CAS  Google Scholar 

  438. 438. G. P. Collett and F. C. Campbell, Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 25, 2183–2189 (2004).

    Article  PubMed  CAS  Google Scholar 

  439. 439. S. C. Wei, Y. S. Lin, P. N. Tsao, J. J. Wu-Tsai, C. H. Wu, and J. M. Wong, Comparison of the anti-proliferation and apoptosis-induction activities of sulindac, celecoxib, curcumin, and nifedipine in mismatch repair-deficient cell lines. J Formos Med Assoc 103, 599–606 (2004).

    PubMed  CAS  Google Scholar 

  440. 440. G. Song, Y. B. Mao, Q. F. Cai, L. M. Yao, G. L. Ouyang, and S. D. Bao, Curcumin induces human HT-29 colon adenocarcinoma cell apoptosis by activating p53 and regulating apoptosis-related protein expression. Braz J Med Biol Res 38, 1791–1798 (2005).

    Article  PubMed  CAS  Google Scholar 

  441. 441. K. Singletary, C. MacDonald, M. Wallig, and C. Fisher, Inhibition of 7,12-dimethylbenz[a]anthracene (DMBA)-induced mammary tumorigenesis and DMBA-DNA adduct formation by curcumin. Cancer Lett 103, 137–141 (1996).

    Article  PubMed  CAS  Google Scholar 

  442. 442. S. S. Deshpande, A. D. Ingle, and G. B. Maru, Chemopreventive efficacy of curcumin-free aqueous turmeric extract in 7,12-dimethylbenz[a]anthracene-induced rat mammary tumorigenesis. Cancer Lett 123, 35–40 (1998).

    Article  PubMed  CAS  Google Scholar 

  443. 443. K. Singletary, C. MacDonald, M. Iovinelli, C. Fisher, and M. Wallig, Effect of the beta-diketones diferuloylmethane (curcumin) and dibenzoylmethane on rat mammary DNA adducts and tumors induced by 7,12-dimethylbenz[a]anthracene. Carcinogenesis 19, 1039–1043 (1998).

    Article  PubMed  CAS  Google Scholar 

  444. 444. H. Inano, M. Onoda, N. Inafuku, M. Kubota, Y. Kamada, T. Osawa, H. Kobayashi, and K. Wakabayashi, Chemoprevention by curcumin during the promotion stage of tumorigenesis of mammary gland in rats irradiated with gamma-rays. Carcinogenesis 20, 1011–1018 (1999).

    Article  PubMed  CAS  Google Scholar 

  445. 445. R. Kuttan, P. Bhanumathy, K. Nirmala and M. C. George, Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett 29, 197–202, (1985).

    Article  PubMed  CAS  Google Scholar 

  446. 446. M. Nagabhushan and S. V. Bhide, Curcumin as an inhibitor of cancer. J Am Coll Nutr 11, 192–128 (1992).

    PubMed  CAS  Google Scholar 

  447. 447. S. S. Hecht, P. M. Kenney, M. Wang, N. Trushin, S. Agarwal, A. V. Rao, and P. Upadhyaya, Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice. Cancer Lett 137, 123–130 (1999).

    Article  PubMed  CAS  Google Scholar 

  448. 448. A. Khar, A. M. Ali, B. V. Pardhasaradhi, Z. Begum, and R. Anjum, Antitumor activity of curcumin is mediated through the induction of apoptosis in AK-5 tumor cells. FEBS Lett 445, 165–168 (1999).

    Article  PubMed  CAS  Google Scholar 

  449. 449. M. Churchill, A. Chadburn, R. T. Bilinski, and M. M. Bertagnolli, Inhibition of intestinal tumors by curcumin is associated with changes in the intestinal immune cell profile. J Surg Res 89, 169–175 (2000).

    Article  PubMed  CAS